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Abstract. Sue 6,12:dihydro-l-benzopyrano[3,4-b][I,4]benzothi-
azin-6-ones and three coumarins were systematically investigated 
for reversal of multidrug resistance of bacteria and cancer cells in 
model experiments. 7-Methylcoumarin was able to eliminate the 
E. coli plasmid significantly; however, the other derivatives were 
ineffective. Four of 6,12-dihydro-l-benzopyrano[3,4-b][l,4] 
benzothiazin-6-ones had a moderate effect on the multidrug 
resistance efflux pump of mouse lymphoma cells in vitro. Despite 
of the similarity of resistance mechanisms of bacteria and tumor 
cells, the reversal of drug resistance in bacteria and in cancer 
cells is not uniform because the structure- activity requirements 
are apparently different. 
In cancer therapy, the development of resistance, including 
multidrug resistance for traditionally used medicines, is now a 
major problem. Patients need new type of medicines or 
special drugs to reduce the drug resistance. Therefore, some 
benzo[a]phenothiazines were planned for synthesis in our 
laboratories. As shown earlier, benzo[a]phenothiazines have 
antitumor activity against some tumor cells (1), induce 
significant apoptosis on human myelogenous leukemic cell 
lines such as ML-1, U-937 and THP-1 (2), and affect the 
element content of tobacco tissue culture and hormone 
requirement (3). 6,12-Dihydro-l-benzopyrano[3,4-b][l,4]ben-
zothiazin-6-ones are structurally very similar to the structures 
of benzo[a]phenothiazines (Figure 1). Some 6,12-dihydro-l-
benzopyrano[3,4-b][l,4]benzothiazin-6-ones showed an effect. 
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on the multidrug resistance efflux pump of mouse lymphoma 
cells in vitro (4). The coumarins which are included in these 
compounds have also shown antitumor activity by the 
inhibition of HIV integrase (5). Based on our estimated 
structure-activity relationship, it was expected that 6,12-
dihydro-l-benzopyrano[3,4-h][l,4]benzothiazin-6-ones may 
have some antitumor activity and may cause reversal on 
resistant tumor cells. The purpose of this paper is to show the 
mdr reversal activity of seven 6,12-dihydro-l-benzo-
pyrano[3,4-i»][l,4]benzothiazin-6-ones on tumor cells with 
multi-drug resistance. 
Materials and Methods 
Melting points were determined in open glass capillaries in a paraffin 
bath and are uncorrected. >H-NMR spectra were performed on a JEOL 
JNM-GSX 500 (500 MHz) spectrometer using TMS as internal standard 
(5=0). Aromatic protons are represented as ArH. Infrared (IR) spectra 
were recorded on a JASCO IR810 spectrometer. Mass spectra (MS) 
were recorded on a JEOL-JMS-DX300 spectrometer with direct inlet 
system at 70eV. TLC (Thin layer chromatography) was performed on a 
Merck Kieselgel 60 F254 (Merck 5549, USA). 
Chemicals. Phenols were purchased from SISCO Chem Industries, 
Bombay, India. Phosphorus oxychloride was purchased from 
Spectrochem private limited Bombay, India. Zinc chloride was made 
anhydrous by fusion and then used. 6-Methylcoumarin [13](Aldrich, 
M3,620-3); 7-methylcoumarin [!4](Aldrich, 22,032-9); ethyl 3-
coumarincarboxylate [15](Aldrich, 39.080-1) and rhodamine 123 hydrate 
(R123)(Aldrich, 28394-0) were purchased from Aldrich Chemical Co. 
(Milwaukee, WI, U.S.A.). (i)-Verapamil (Sigma, V 4629) as calcium 
channel blocker (3,5) was purchased from Sigma Chemical Co. (St. 
Louis, MO, U.S.A.). 
General method of preparation of 4-hydroxycoumarins [1-6]. 4-Hydro-
xycoumarins [1-6] were prepared according to the methods of Shah and 
Bose (6,7). Phenol or substituted phenol (0.1 M) and malonic acid (0.1 
M) were added to a mixture of 30 ml. phosphorus oxychloride and 36 g 
anhydrous zinc chloride, which was preheated to 60*C and the reaction 
mixture was heated on a water bath at 70'C for 16-36 hours. After the 
reaction had finished, it was cooled and decomposed with crushed ice, 
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the product was crystallized and was filtered, followed by washings with 
water. The product was dissolved in 10% sodium carbonate, warmed if 
neccessary and filtered. The filtrate was slowly acidified with 3 M HC1 till 
complete precipitation, then filtered, washed with water, dried and 
recrystallized from EtOH or AcOH (Scheme 1). 
The following compounds were obtained: 
a) 4-Hydroxycoumarin [1], Yellow powders (EtOH). mp:209-210"C (Lit. 
6: mp 201-203°C). 
b) 6-Methyl-4-hydroxycoumarin ¡2], Yellow powders (EtOH). mp:251-
253°C (Lit. 8: mp 240°C). 
c) 5,7-Dimethyl-4-hydroxycoumarin [3], White powders (AcOH). 
mp:210-211°C (Lit. 7: mp 210-211°C). 
d) 5,8-Dimethyl-4-hydroxycoumarin [4], Yellow powders (EtOH). 
mp:261-262°C (Lit. 9. mp 261-262°C). 'H-NMR (60 MHz, TFA) 6: 
2.47 (s, 3H, CH3) , 2.49 (s, 3H, CH3) , 6.22 (s, 1H, H-3), 7.41 (br s, 1H, 
ArH), 7.60 (brs , 1H, ArH). 
e) 7,8-Dimethyl-4-hydroxycoumarin [5], Yellow powders (EtOH). 
mp:236-237°C (Lit. 7: mp 236-237'C). 
f) 6-Chloro-7-methyl-4-hydroxycoumarin [6], Yellow powders (EtOH). 
mp:229-230"C (Lit. 7: mp 229-230X). 
General method of preparation of 6,12-dihydro-l-benzopyrano[3,4-
b][ l,4]benzothiazin-6-ones [7-12], 6,12-Dihydro-1 -benzopyrano[3,4-
6][l,4]benzothiazin-6-ones [7-12] were prepared according to the 
method of K.Tabakovic et al (10). A mixture of appropriate 4-
hydroxycoumarin [1-6] (0.01M) and 2-aminothiophenol (0.01M) in 25-30 
mL DMSO was stirred and heated at 140-150X for 10-13 hours. At the 
stage when the reaction mixture became dark, heating was stoped and 
the mixture slowly distilled in an excess of approximately 15-17 mL 
DMSO at atmospheric pressure. The reaction mass was then cooled to 
obtain dark colored crystallized product. This product was washed with 
MeOH and purified by three time washings and its purity was checked by 
TLC using CH 2 C l 2 -MeOH (10cl) system (Scheme 1). 
The following compounds were obtained: 
a) 6,12-Dihydro-l-benzopyrano[3,4-b][l,4]benzothiazin-6-one [7], 
Reddish brown crystals. mp:337-340X (MeOH) (Lit. 10: mp 337-
340 X ) . 
b) 2-Methyl-6,12-dihydro- 1-benzopyrano[3,4-b][ 1,4jbenzothiazin-6-one 
[8], Dark orange crystals. m p : 3 4 0 X (MeOH). yield: 50%. 1H-NMR 
(DMSO-d6) 6: 2.40 (s, 3H, CH 3) , 6.82-6.88 (m, 2H, ArH), 6.95-7.20 
(m, 2H, ArH), 7.26 (d, 1H, 7=8.2 Hz, ArH), 7.44 (d, 1H, 7=8.5 Hz, 
ArH), 7.92 (s, 1H, ArH), 8.94 (s, 1H, NH). IR (Nujol) cm"1: 3350 
(NH), 1655 ( C = 0 ) . MS m/e: 281 (M+, 100%). High-resolution MS: 
Calcd for C i 6 H n N 0 2 S : 281.0511. Found: 281.0506. 
c) l,3-Dimethyl-6,12-dihydro- 1-benzopyrano[3,4-b][ 1,4]benzothiazin-6-
one f 9 f . Green crystals. m p : 2 9 0 X (MeOH). yield: 52%. 1H-NMR 
(DMSO-d6) 6: 2.33 (s, 3H, CH3) , 2.65 (s, 3H, CH 3) , 6.68-6.73 (m, 1H, 
ArH), 6.79-6.85 (m, 1H, ArH), 6.87-6.98 (m, 3H, ArH), 6.98-7.40 (m, 
1H, ArH), 10.10 (br s, 1H, NH). IR (Nujol) cm"1: 3300 (NH), 1630 
( C = 0 ) . MS m/e: 295 (M+, 100%). High-resolution MS: Calcd for 
C i 7 H i 3 N 0 2 S : 295.0667. Found: 295.0653. 
d) l,4-Dimethyl-6,12-dihydro-l-benzopyrano[3,4-b][l,4]benzothiazin-6-
one [10]. Light green crystals, mp: 1 7 0 X (MeOH). yield: 50%. 1H-
NMR (DMSO-d6) 6: 2.26 (s, 3H, CH 3) , 2.53 (s, 3H, CH3), 6.35-6.45 
(m, 1H, ArH), 6.65-6.76 (m, 1H, ArH), 6.80-7.10 (m, 3H, ArH), 7.28-
7.37 (m, 1H, ArH), 7.96 (br s, 1H, NH). IR (Nujol) cm"1: 3300 (br, 
NH), 1670 ( C = 0 ) . MS m/e: 295 (M+, 100%). High-resolution MS: 
Calcd for C i 7 H 1 3 N 0 2 S : 295.0667. Found: 295.0654. 
e) 3,4-Dimethyl-6,12-dihydro-1 -benzopyrano[3,4-b][l,4]benzothiazin-6-
one [11], Orange crystals. m p : > 3 0 0 X (MeOH). yield: 50%. 1H-
NMR (DMSO-dft) 6: 2.24 (s, 3H, CH 3) , 2.35 (s, 3H, CH3), 6.82-6.87 
(m, 2H, ArH), 6.96-7.02 (m, 2H, ArH), 7.24 (d, 1H, 7=8.2 Hz, ArH), 
7.86 (d, 1H, 7=8.2 Hz, ArH), 8.94 (s, 1H, NH). IR (Nujol) cm"1: 3340 
Benzo[a]phenothiazine 6,12-dihydro-l-benzopyra[3,4-
4]benzothiazin-6-ones[7-12] 
Figure 1. Benzofajphenothiazine and 6,12-dihydro- l-benzopyrano[3,4-
b][l,4jbenzothiazin-6-ones [7-12], 
(NH), 1655 ( C = 0 ) . MS m/e: 295 (M+, 100%). High-resolution MS: 
Calcd for C 1 7 H i 3 N 0 2 S : 295.0667. Found: 295.0667. 
f) 2-Chloro-3-methyl-6,12-dihydro-l-benzopyrano[3,4-b][ 1,4] benzothiazin-
6-one [12]. Reddish brown crystals. m p : 3 2 8 X (MeOH). yield: 45%. 
'H-NMR (DMSO-ds) 6: 2.40 (s, 3H, CH 3) , 6.83-6.87 (m, 2H, ArH), 
6.94 (d, 1H, 7=7.6 Hz, ArH), 6.97-7.01 (m, 1H, ArH), 7.42 is, 1H, 
ArH), 8.25 (s, 1H, ArH), 8.98 (br s, 1H, NH). IR (Nujol) cm" : 3350 
(NH), 1660 ( C = 0 ) . MS m/e: 315 + 317 (3:1) ( M + , 100%: 38.6%). 
High-resolution MS: Calcd for C i 6 H i 0 3 7 CINO 2 S: 315.0121. Found: 
315.0129. Calcd for C i6H1 0 3 7C1NO2S: 317.0091. Found: 317.0085. 
Biological evaluation 
Measurement of antiplasmid activity. The F'lac plasmid of E. coli served 
as a convenient model in this study because the plasmid carrying 
colonies were easily differentiated from the plasmidless colonies on a 
simple eosinum methylene blue (EMB)-differential media. The 
antiplasmid activity of test compounds was measured on E. coli K12 
LE140 F'lac strain in MTY broth which contained various 
concentrations of test compounds (11,12). After 24 hours of incubation 
at 37 X , various dilutions of samples were plated on EMB agar. The 
lactose-positive (plasmid earring) colonies and lactone-negative 
(plasmidless) colonies were counted (Table I). 
Tissue cultures. L5178 mouse T cell lymphoma and its MDR1/A 
retrovirus transfected derivative were provided from Prof. Aszalos 
(Table II). 
Cell and fluororescence uptake. MDR1/A expressing cell lines were 
selected by culturing the infected cells with 60 ng/mL colchicine to 
maintain the expression of the mdr phenotype. The L5178 M D R cell 
line, and the L5178Y parent cell line were grown in McCoy's 5A medium 
with 10% heat-inactivated horse serum, L-glutamine and antibiotics. The 
cells were adjusted to a concentration of 2 x lOtymL and resuspended in 
serum-free McCoy's 5A medium and the cells were distributed into 0.5 
mL aliquots to Eppendorf centrifuge tubes. Then, the tested compounds 
were added in 2.0 pL of the 2.0 mg/mL stock solution and the samples 
were incubated for 10 minutes at room temperature. Then. 50 pL 
rhodamine 123 (R123) as indicator was added to the samples (5.2 pM 
final concentration) and the cells were incubated for a further 20 
minutes at 3 7 X , washed twice and resuspended in 0.5 mL phosphate-
buffered saline (PBS) for analysis. The fluorescence of the cell 
population was measured by flow cytometry using Beckton Dickinson 
FACScan instrument (cell sorter). (±)Verapamil was used as the 
positive control in the R123 accumulation experiments (13,14). The 
R123 accumulation was calculated from fluorescence of one height value 
x 
using the 2nd equation y=10 256 (Table II). In the case of logarithmic 
transformation, the 1024 digital channels were switched to one decade at 
each 256 (=28) channels. Then, the percentage of control mean of the 
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O^ OH Y > a X\ 0 H OH R< Zna2,POCl3 
60-70° 
several hrs 
1: RI = H, R2=H, R3=H, R4=H 
2: RI=H, R2=CH3, R3=H, R4=H 
3: RI=CH3, R2=H, R3=CH3, R4=H 
4: RI=CH3, R2=H, R3=H, R4=CH3 
5: R! = H,.R2=H, R3=CH3, R4=CH3 
6: RI=H, R2=C1, R3=CH3, R3=H 
DMSO 
140-150° 
7: R] = H. R2=H, R3=H, R4 = H 
8: RI = H, R2=CH3, R3=H, R4 = H 
9: R)=CH3, R2=H, R3=CH3, R4=H 
10: RI=CH3, R2=H, R3=H, R4=CH3 
II: RI = H, R2=H, R3=CH3. R4=CH3 
12: RI=H, R2=CI, R3=CH3, R3=H 
Scheme 1. Synthesis of 6,12-dihydro-l-benzopyrano/3,4-b][l,4]benzothiazin -6-ones[7-12], 
fluorescence intensity was calculated for parental and mdr cell lines, 
compared to untreated cells. An activity ratio was calculated by the 
following equation (13,15)(Table II): 
Table I. Antiplasmid activity of 6,12-dihydro-l-benzopyrano]3,4-
b/[I,4]benzothiazin-6-ones 17-12] and related coumarins [13-15], 
Rat io= 
(mdr t reatedImdr control) 
(parental treated/parental control) 
Results and Discussion 
Antiplasmid activity by elimination of F'lac. Antiplasmid 
activity by elimination of F'lac was tested and only one 
compound the 7-methylcoumarin [14] had a remarkable 
effect, while three other derivatives [ 8 ] , [ 1 1 ] and [ 1 2 ] had 
slight effect. The other coumarins [7, 9, 10, 13, 15] were 
ineffective (Table I). 
The activity of 7-methylcoumarin [14] is probably related to 
the electrophilic-superdelocalization induced by methyl 
substitution at 7 position. If this correlation were true then we 
would expect similar effects in case of compounds [9, 11, 12]; 
however, these compounds were weak. The effect of [9] was 
reduced by methylation at position 1 due to a compensating 
electronic distribution. 
mdr Reversal on tumor cells. The effect of 6,12-dihydro-l-
benzopyrano[3,4-i>][l,4]benzothiazin-6-ones [7-12] and 
coumarins [13-15] was tested on the mdr reversal on tumor 
cells. The coumarins used in this study were slightly effective 
(Table II). Three 6,12-dihydro-l-benzopyrano[3,4-6][l,4]ben-
zothiazin-6-ones of [8] (Fluorescence activity ratio, 1.56), [9] 
(Fluorescence activity ratio, 1.43) and [10] (Fluorescence 
activity ratio, 1.11) at 20 pg concentration had a moderate 
activity on mdr reversal (Fluorescence activity ra t io>l) . 
However, three 6,12-dihydro-l-benzopyrano[3,4-6][l,4]benzo-
thiazin-6-ones [7,11,12] (Fluorescence activity ratios, 0.57, 
R 
"rat] 
10 O C ) 9 8 F 
«2 2JT Ra 
T U 
o 6 
Compd's 
No. 
Ri Rz R3 Ra Elimination 
of F'lac 
(pg/mL) 
Antiplasmid 
effect 
(%) 
7 H H H H 200 0 
8 H CH3 H H >200 0.05/at 160 pg 
9 CH3 H CH3 H 200 0 
10 CH3 H H CH3 200 0 
11 H H CH3 CH3 200 0.1/at 160 pg 
12 H CI CH3 H >200 0.9/at 180 pg 
1 3 
(6-methylcoumarin) 
14 
(7-methylcoumarin) 
15 
(ethyl 3-coumarin-hyphen 
carboxylate) 
CH3CH2O/' 
200 
95 
200 
32.0/at 70 pg 
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Table II. The effect of 6,12-dihydro-l-benzopyrano[3,4-b][l-4]benzothiazin-6-ones [7-12] and related coumarins [ 13-15] on the mdr reversal on L-5178 
tumor cells with multidrug resistance. 
Compound's 
number 
Concentration 
(Pg) 
Forward 
scatter 
count 
(cell size) 
Side scatter 
count 
(granulation 
of cell) 
Fluorescence one height" Fluorescence 
activity 
ratioc 
b 
X 
X 
256 
X 
256 
y=10 
<0 par ' control 501.31 335.65 781.9520 3.0545 1133.80 -
mdr + R123e ) control 552.47 385.44 326.0672 1.2737 18.78 1 . 0 0 
(±)-veraparnil r ) 8 p g 540.50 381.20 563.8161 2.2024 159.37 8.49 
7 
2(Spg 
551.31 
533.43 
375.07 
400.03 
246.9632 
263.5264 
0.9647 
1.0294 
9.22 
10.70 
0.49 
0.57 
8 
2<$Pg 
557.39 
541.54 
375.09 
388.52 
263.6261 
375.3984 
1.0298 
1.4664 
10.71 
29.27 
0.57 
1.56 
9 
2(Tpg 
553.48 
544.72 
379.05 
375.61 
298.3680 
366.0288 
1.1655 
1.4298 
14.64 
26.90 
0.78 
1.43 
10 
2(fpg 
551.91 
543.69 
385.77 
380.65 
291.9680 
337.7408 
1.1405 
1.3193 
13.82 
20.86 
0.74 
1.11 
11 
2(fpg 
540.58 
553 07 
368.60 
374.34 
235.6851 
269.1072 
0.9206 
1.0512 
8.33 
11.25 
0-44 
0.60 
12 
2(Tpg 
550.50 
544.76 
386.64 
382.16 
251.5712 
275.4304 
0.9827 
1.0759 
9.61 
11.91 
0.51 
0.63 
13 
2(fpg 
558.61 
559.92 
396.64 
389.56 
254.8736 
252.8512 
0.9956 
0.9877 
9.90 
9.72 
0.53 
0.52 
14 2 p g 559.13 393.86 265.9840 1.0390 10.94 0.58 
15 2 Pg 
20 pg 
522.56 
513.96 
397.48 
371.64 
264.1408 
275.8144 
1.0318 
1.0774 
10.76 
11.95 
0.57 
0.64 
a Ref . l5 . bx: Measured fluorescence value at linear scale [pg, uptake of R123]. " 
°The R-123 accumulation was calculated from fluorescence of one height value using 1st equation = 10 2 5 6 ; the fluorescence activity ratios were 
calculated according to the formula given below; 
(mdr treated/mdr control) 
Ratio = 
(parental treated/parental control) 
dpar: parental without multidrug resistant gene; cmdr: parental with multidrug resistant gene. 
f(±)-verapamil: a control for mdr reversal. 
0.60 and 0.63, respectively) without methyl or benzo group at 
positions 1 or 2 together reduced the rhodamine 
accumulation in tumor cells, probably by inducing the efflux 
pump mechanism or by causing a direct membrane injury 
(Table II). Position 4 must be free or low in electron density 
for the mdr reversal effect. The one exception is [10], in which 
the substitutions at positions 1 and 4 neutralized each other. 
The ineffectivity of the compounds was probably correlated 
with the lower or reduced cell size, however, granulation did 
not change remarkably in the cells. There was no toxic effect 
in the applied concentration, and the cell size did not change 
in flow cytometry. 
References 
1 Motohashi N: Test for antitumor activities of phenothiazincs and 
phenoxazines. (in Japanese) Yakugaku Zasshi 103: 364-371, 1983; Chem 
Abst 99: 231v, 1983. 
2 Motohashi N, Sakagami H, Kamata K and Yamamoto Y: Cytotoxicity and 
differentiation-inducing activity of phenothiazine and bcnzo[a]phe-
nothiazine derivatives. Anticancer Res 11: 1933-1938,1991. 
3 Szabó M, Csiszár J, Rausch H, Molnár J and Motohashi N: Influence of 
benzo[a¡phenothiazincs on the element content of two tobacco tissue 
cultures differing in hormone requirement. Anticancer Res 17: 2049-2056, 
1997. 
4 Shah A, Naliapara Y, Sureja D, Motohashi N, Kurihara T, Kawase M, 
Satoh K, Sakagami H and Molnár J: Biological activity of 6,12-dihydro-l-
benzopyrano[3.4-6][l,4]benzothiazin-6-ones. Anticancer Res 18: in press, 
1998. 
5 Zhao H, Neamati N, Hong H, Mazumder A, Wang S, Sunder S, Milne 
GWA, Pommier Y and Burke TR: Coumarin-based inhibitors of HIV 
integrase. J Med Chem 40: 242-249, 1997. 
6 Shah VR. Bose JL and Shah RC: New synthesis of 4-hydroxycoumarins. J 
Org Chem 25: 677-678, 1960. 
7 Shah AK. Bhatt NS, Raval RV and Thakor VM: Synthesis of 4-
hydroxycoumarins. Curr Sci 53: 1241-1242,1984. 
8 Ziegler H and Junek H: A new synthesis of 4-hydroxycoumarin and its 
derivatives. Monatsch Chem 86: 29-38,1955. 
9 Shah A: Ph.D. Thesis, Saurashta University, Rajkot, 1982. 
10 Tabakovic K, Tabakovic I, Trkovnik M, Juric A and Trinajstic N: Studies 
on novel heterocyclic ring systems. Reaction of 4-hydroxycoumarin with o-
aminobenzaldehyde and 2-mercaptoaniline. J Heterocyclic Chem 17: 801-
803,1980. 
11 Motohashi N, Sakagami H, Kurihara T, Csuri K and Molnár J: 
Antiplasmid activity of phenothiazines, benzofajphenothiazines and 
benz[c]acridines. Anticancer Res 12: 135-140,1992. 
12 Molnár J. Kiraly J and Mandi Y: The antibacterial action and R-factor 
inhibiting activity by chlorpromazine. Experimentia 31: 444-445,1975. 
13 Weaver JL, Szabo G, Pine PS, Gottesman MM, Goldenberg S and Aszalos 
A: The effect of ion channel blockers, immunosuppressive agents, and 
other drugs on the activity of the multi-drug transporter. Int J Cancer 54: 
456-461.1993. 
14 Kessel D: Exploring multidrug resistance using rhodamine 123. Cancer 
Commun 145-149, 1989. 
15 Weber J. Salgaller M. Samid D, Johnson B, Herlyn M, Lassam N, 
Treisman J and Rosenberg SA: Expression of the MAGE-1 tumor antigen 
is up-regulated by the demethylating agent 5-aza-2'-deoxycytidine. Cancer 
Res 54: 1766-1771, 1994. 
Received November 3, 1997 
Accepted December 12, 1998 
3004 
ANTICANCER RESEARCH I9:5075-5078 (1999) 
Plasmid Elimination and Immunomodulation by 3-Benzazepines 
in Vitro 
NOBORU MOTOHASHI1, MASAMI KAWASE2, SETSUO SAITO2, CSILLA MISKOLCI3, LÍVIA BEREK3 
and JOSEPH MOLNÁR3 
'Meiji Pharmaceutical University, Tokyo, Japan:2 Faculty of Pharmaceutical Sciences, Josai University, Saitama, Japan; 
3Department of Microbiology, Albert Szent-Györgyi Medical University, Szeged, Hungary 
Abstract. For studying the mechanisms of biological activity on 
3-benzazepines, antimicrobial effect, F'lac plasmid elimination 
activity (a plasmid curing effect on F'lac plasmid) and antibody-
dependent cellular cytotoxicity (ADCC) test were peiformed. A 
weak antiplasmid effect was found at sub-inhibitory con-
centrations. A combination of [KF4] with verapamil [2] did not 
alter the ineffectivity, however, [KF4] could inhibit the 
antiplasmid effect of promethazine, as compared to the control 
(promethazine alone) plasmid curing effect. A competition 
between promethazine and [KF4] might exist in plasmid 
elimination effect. ADCC activity of human leukocytes was 
enhanced by KF1, KF2, KF3, DA and NE at 1.0 fig/mL 
concentrations. The majority of 3-benzazepines [KS02, KM57, 
KN50, KE04, KI10, KPSO] was ineffective for plasmid curing, 
however, inhibited the ADCC reaction, but they did not show a 
real dose-dependent effect. 
3-Benzazepines have been tested for anti-plasmid. DNA-
complexing, reversal of multidrug resistance (MDR) of tumor 
cells, inhibitory effects of reverse transcriptase of Moloney 
leukemia virus, and cytotoxic activity for HL-60 cells (1, 2). A 
phenothiazine and its derivatives have a plasmid curing effect 
on F'lac plasmid and other plasmids of a multiple antibiotic 
resistant E. coli (3, 4, 5). The purpose of this paper was to 
investigate the synergism, additive effect and antagonism on 
plasmid-eliminating activity of 3-benzazepines with known 
resistance modifiers such as promethazine or verapamil. 
Compound [KP80] (ST450570) seems to have reasonable 
activities against all 60 cancer cell lines (7). 
Materials and Methods 
Chemicals. KS02, KM57, K.N50, KE04, KI10. KP80, KF1-KF4. dopamine 
(DA) and norepinephrine (NE) were obtained previously (9). The 
Correspondence to: Prof. Noboru Motohashi, Mciji Pharma-
ceutical University, 2-522-1 Noshio. Kiyose-shi, Tokvo, 204-
8588, Japan. Tel and Fax: (+)-8l-424-95-8953. • 
Key Words: 3-Benzazcpines, plasmid elimination. 
following chemicals and reagents were obtained from the indicated 
companies: promethazine (pipolphen) (EGYT, Budapest, Hungary) and 
verapamil [VP] (Chinoin, Budapest, Hungary) (Table I). 
Bacterial strain. Escherichia coli K12 LE140 (T6r, Tis, SmR, lac" 
delta, Su", lR , Mai"). 
Culture media. Tryptone-yeast extract (MTY) liquid media was used for 
the cultivation and the determination of live cell counts in the cultures. 
Eosin-methylene blue (EMB) agar was used for the differentiation of lac 
negative (lac') and lac positive (lac+) colonies (8). 
Assay for F'lac plasmid elimination activity. An overnight preculture of 
Escherichia coli K12 LE140 was diluted 10"4 and inoculated in 0.05 mL 
aliquots (approximately 5 x 103 cells) into 5.0 mL MTY nutrient broth. 
The various concentrations of promethazine (20-100 pg/mL), KS02, 
KM57, KN50, KE04, KU0, KP80, KF1-KF4, D A and NE (20-200 
pg/mL) were added to the bacterial cultures. Combinations of 
promethazine (20-100 pg/mL) plus [KF4] (100 pg/mL), or combinations 
of verapamil (200 pg/mL) plus [KF4] (10-100 pg/mL) were added 
respectively, and the tubes were incubated at 37*C for 24 hours without 
shaking. Two dilutions with 10'4 and 10"5 concentrations were prepared 
from tubes showing growth and plated in 0.1 mL amounts on EMB agar. 
The plates were incubated at 37 'C for 24 hours, then counted for lac" 
plasmidless (pink) and lac+ plasmid containing (deep violet) colonies. 
The percentage (%) of plasmid elimination was counted. 
Isolation of mononuclear cells. The compounds were dissolved in DMSO, 
final concentrations were 1.0, 5.0, 10.0 pg/mL, in all triplicate test 
cultures. Both control cultures and test cultures contained DMSO in the 
same concentration. Human peripheral blood mononuclear cells (PBM) 
were isolated from five healthy blood donors by Ficoll-Uromiro 
(Pharmacia LKB, Bracco Ind. Chim, France) gradient centrifugation. 
The cells were washed and resuspended in RPMI-1640 medium (Gibco, 
Grand Island, NY, U.S.A.) supplemented with 10% fetal calf serum 
(Gibco, Grand Island. NY, U.S.A.), 100 IU/mL penicillin, 100 pg/mL 
streptomycin sulfate and 2 mM L-glutamine. Monocyte-free peripheral 
blood mononuclear cells (PBM-Mo') was prepared by treating the 
freshly drawn heparinized blood at 37*C for 5 min with carbonyl iron 
powder, before separation on Ficoll-Uromiro gradient. Viability of the 
cells incubated with the drugs were determined by trypan blue stain after 
4 hr incubation (6). 
Antibody-dependent cellular cytotoxicity (ADCC) test. Human O Rh-
positive red blood cells (used as target) and PBM-Mo' (used as effector) 
were mixed at 1:10 ratio. The reaction was mediated by red blood cell 
specific anti-Rh(D) antibody (6). The cultures were incubated at 37*C 
for 16 hr and the amount of released 51Cr into the culture supernatants 
was determined with gamma-counter. From the average of triplicate 
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Table 11. F'lac plasmid elimination of 3-benzazepines and related 
compounds. 
Compound Concentration Plasmid 
(pg/mL) elimination 
(mean %) 
control 0 0.00 
promethazine 20 0.00 
40 0.00 
60 20.95 
80 84.00 
100 -(MIC) 
Benzazepinones 
KS02 20 0.45 
40 0.00 
100 0.00 
200 18.75 
KM57 20 0.59 
40 0.15 
100 0.00 
200 13.76 
K.N50 20 0.00 
40 0.00 
100 0.37 
200 21.88 
KE04 20 0.01 
40 0.00 
100 0.00 
200 0.00 
KI10 20 13.33 
40 0.20 
100 0.00 
200 0.00 
KP80 20 0.00 
40 0.00 
100 0.05 
200 -(MIC) 
Benzazepines 
KF1 20 0 77 
40 0.13 
100 2.44 
200 -(MIC) 
KF2 20 0.00 
40 0.14 
100 1.60 
200 -(MIC) 
K.F3 20 0.00 
40 0.045 
100 1.20 
200 -(MIC) 
KF4 20 0.00 
40 0.00 
100 0.00 
200 0.00 
Dopamines 
DA 20 0.00 
40 0.00 
100 0.38 
200 0.00 
NE 20 0.00 
40 0.00 
100 0.00 
200 0.14 
Table I. Structures of six 2,3.4.5-letrahydro-lH-3-benzazepinones [ 1-61, 
four 2,3,4,5-tetrahydro-1 H-3-benzazepines 17-10], two catechols [11, 12] 
and promethazine used in this study" . 
/ C H 3 
CH2CHN(CH3)2 
: ;xxKJCCh 060 
o 
[1-6] [7-10] 
promethazine 
Compound RL R2 R 3 
Benzazepinones 
KS02[ 1 ] MeO • Ms Me 
KM57[2] MeO Tf Me 
KN50[3] H Tf H 
KE04[4] MeO Tf H 
KI10[5] MeO Tf Me2CH 
KP80[6] MeO Tf Ph 
Benzazepines 
KF1[7] HO H CF3 
KF2[8] HO Me CF3 
KF3[9] HO H H 
KF4J10] MeO H CF3 
Dopamines 
DA [11] 
NE [12] 
HO 
H O 
H O 
- K ^ F L NH ? 
O H 
XX^NH, 
j Cytotoxicity = 100 x 
test M Cr release - spontaneous s l Cr release 
maximum MCr release - spontaneous ^'Cr release 
a) abbreviations. Me: CH3 ; Ms: SO2CH3: 
Tf: SO2CF3. 
released values, the percentage of cytotoxicity was calculated by the 
following formula. 
Spontaneous release indicated those cultures without anti-D antibody. 
The results are expressed in percent of control cultures. 
Results and Discussion 
Antimicrobial effect. The antimicrobial action of 3-
benzazepines is very small. The majority of compounds had 
no MIC values below 200 pg/mL. Antiplasmid effects and ion 
mutant selection are insignificant even at 320 pg/mL (data not 
shown). 
The antiproliferative effects on parental control (Par) and 
MDR tumor cell lines were the same, resulting in a high 
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Table III. E. coli F'lac plasmid elimination by a combination of 
promethazine with KF4 [10], 
Compound Concentration 
(pg/mL) 
Plasmid 
elimination (%) 
control 0 0.00 
promethazine 20 0.00 
40 0.10 
60 3.52 
80 70.6 
100 -(MIC) 
promethazine + KF4[10] 20 + 100 0.00 
40 + 100 0.00 
60 + 100 0.00 
80 + 100 0.00 
100 + too 0.00 
Verapamil + KF4[10] 200 + 10 0.00 
200 + 20 0.00 
200 + 50 0.00 
200 + 100 0.00 
Table IV. ADCC activity in the presence of 3-benzazepines. ''' 
Compound A D C C activity (% of control) 
1 (pg/mL) 5 (pg/mL) 10 (pg/mL) 
control 62 51 44 
Benzazepinones 
KS02[1] 74 85 93 
KM57[2] 79 85 83 
KN50[3] 51 62 70 
KE04[4] 60 57 66 
K110[5] 30 34 23 
KP80[6] 83 78 74 
Benzazepines 
KF1 [7] 1043> 1273) 1253) 
KF2[8] 91 1113» 97 
KF3[9] 1013> 1233) 1063) 
KF4[10] 96 1193» 84 
' T h e target-effector ratio was 1: 10. 2)Basic ADCC activitv: without 
DMSO = 50%. ^Enhancing effect of 3-benzazepines: over 100%. 
toxicity. The growth inhibitory effect was found in the 
experiment as follows: 50% growth inhibitory concentration 
(GI50) as follows, lower than GI50 = 0.2 pg/mL: KF1, KF2, 
KF3, DA, NE; GI 5 0 = 3.5 pg/mL: KS02, KM57, KN50, KE04, 
KI10, KP80, KF4. At 5.0 pg/mL, the inoculated cells could not 
grow after three days (Table II). 100% inhibitory 
concentrations for KF1, KF2, KF3, DA and NE was 1 pg/mL. 
Combination of KF4 with verapamil. The combination of 
[KF4] with verapamil did not alter the ineffectivity on plasmid 
elimination (Table III). The effect on reversal of MDR was 
dependent on tertiary nitrogen (N)-atom after methyl 
substitution at 3nd position (R2) of 3-benzazepine ring. For 
reverse transcriptase (RT) inhibition, the R j can be hydroxy, 
however, methoxy substituent at R] cancelled this effects in 
case KF4, despite the fact that methoxy substituent favours 
for DNA complexing effect (2). 
Antiplasmid effect. Compound [KF4] could inhibit the 
antiplasmid effect of promethazine, compared to control 
(promethazine alone) plasmid curing effect. Compound 
[KF4] alone could not eliminate the metabolic plasmid of E. 
coli in the presence of 200 pg/mL of verapamil (Tables II and 
III). This suggests that competition between promethazine 
and [KF4] exists in plasmid elimination effect. Nevertheless, a 
combination of promethazine with verapamil of a known 
multidrug resistance (MDR) modifier was not synergistic 
(data not shown). 
ADCC activity (Interpretation of immunomodulating effect of 
the drug require information about direct cytotoxic potential of 
compounds). A trypan blue indicator assay was used to 
determine the relative number of viable cells in the tested cell 
population. The cell viability was between 85% and 90% with 
all compounds. The reaction was calculated on viable cell 
number (Table IV). 
The majority of 3-benzazepines [KS02, KM57, KN50. 
KE04, KI10, KP80] inhibited the A D C C reaction, but they 
did not show a real dose-dependent effect. Compound [KI10] 
had a significant inhibitory effect which could be detected 
even at low concentrations. Four other 3-benzazepines [KF1-
KF4] caused a low stimulatory effect on ADCC reaction, 
especially [KF1] (Table IV). 
Interestingly, four compounds [KF1-KF4] have some 
enhancing effects on A D C C activity that can be considered as 
immunomodulatory effects, although five other compounds 
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[KS02, KM57, KN50, KE04, KP80] except [KI10] had 
inhibitory effects (Table IV). Based on the modulation of 
ADCC, the ten 3-benzazepines tested can be classified into 
two groups, such as four compounds with enhancing the 
ADCC activation of 3-benzazepines [KF1-KF4] and the other 
six 3-benzazepines [KS02, KM57, KN50, KE04, KI10, KP80], 
which reduced the ADCC. 
As new biological effects of 3-benzazepines are confirmed, 
additional targets for possible plasmid elimination are 
generated. The insights gained in this paper provide optimism 
for effective anticancer chemotherapy in the future. 
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Guanine-cytosine rich regions of plasmid DNA can be the target 
in anti-plasmid effect of phenothiazines 
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Abstract 
The antiplasmid effects of promethazine on E. coli is the consequence of special complex formed with a covalently closed 
circular (ccc) form of plasmid DNA. The exact target in this macromolecule, however, was not clarified until recently. Caffeine 
and the chemically similar guanosine-5'- monophosphate (GMP) could compete with the antiplasmid effect of promethazine, 
showing that promethazine or other phenothiazines preferentially bind to xanthine type molecules. Among the xanthines, G M P 
was more effective at complex-forming than adenosine-5'-monophosphate (AMP). In addition, the Z-DNA was more susceptible 
than B-DNA. Therefore, one could suppose that guanine-cytosine ( G - C ) rich regions have higher affinity than adenine-thymine 
( A - T ) rich region on phenothiazines. Because the G - C rich regions have a special role in the DNA stability via three hydrogen 
bonds, we suppose that these regions could have a key role in some biological effects such as antiplasmid and anticancer activity. 
© 2000 Elsevier Science B.V. and International Society of Chemotherapy. All rights reserved. 
Keywords: Plasmid; Promethazine; Caffeine; Guanosine monophospha te ( G M P ) 
1. Introduction 
T h e pheno th iaz ines have an t ibac te r i a l , an t ip l a smid 
and an t imu tagen ic effects o n va r ious bac ter ia [1 -4 ] , It 
was suggested tha t these ef fec ts can be cor re la ted with 
the b ind ing of pheno th i az ines to nucleic acids by inter-
ca la t ion [5,6], or o t h e r type of c h a r g e t r ans f e r (CT) 
complex f o r m a t i o n [7]. Th i s sugges t ion is based on 
exper imenta l evidence fo r complex f o r m a t i o n be tween 
pheno th iaz ines and m a c r o m o l e c u l e s , such as nucleic 
acids, bacter ia l endo tox in [8], and p ro te in A [9], H o w -
ever, in mos t cases, the types of the b ind ing are not 
exactly k n o w n . T o clar i fy the effect of pheno th i az ines 
on bac te r ia , a s tudy of possible type of in te rac t ion 
be tween pheno th iaz ines a n d nucleic ac ids was s ta r ted . 
T h e de te rmina t ion of the exact b ind ing po in t s is 
diff icult because the mac romolecu le s , such as nucleic 
acid o r pro te ins , have d i f fe ren t g r o u p s which can t ake 
' C o r r e s p o n d i n g author . Tel.; +36-62-455115; fax: + 36-62-
455113. 
pa r t in their b inding . Consequen t ly , in te rac t ions of 
d i f fe ren t types have similar energy a n d cause the s imilar 
changes between or a m o n g the c o r r e s p o n d i n g 
molecules . 
Pheno th i az ine molecules a re heterocycl ic and c o n t a i n 
h y d r o g e n (H) , c a r b o n (C), n i t rogen ( N ) a n d su l fu r (S) 
a t o m s fo r the f o r m a t i o n of the c o o r d i n a t i o n b o n d s . 
Pheno th iaz ines used in medic ine consis t of an a l ipha t ic 
l inker wi th ca t ionic ter t iary N a t o m at the end of the 
l inker a n d side g r o u p s such as O H , CI or C F 3 . A 
c o o r d i n a t i o n b o n d m a y be fo rmed by a n - n s tack ing 
in te rac t ion , ionic in te rac t ion and hydrogen b o n d s 
a m o n g the l inker and side g r o u p s of pheno th iaz ines , 
a n d macromolecu les . A n in terac t ion between nucleic 
acid a n d pheno th i az ine m a y be f o r m e d by the b ind ing 
be tween base moie ty , external sugar and p h o s p h a t e 
moie ty , or by the mul t ip le b ind ings a m o n g l inker a n d 
g r o u p s s imul taneous ly . T h e d i f fe ren t pheno th iaz ines 
m a y p re fe r d i f ferent pa r t s of nucleic acids, consequen t ly 
f o r m i n g the d i f ferent types of associa t ion . Each phe-
no th i az ine could p r o d u c e d i f fe ren t biological effects by 
0924-8579/00/$ 20 £ 2000 Elsevier Science B.V. and International Society of Chemotherapy. All rights reserved 
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the assoc ia t ion be tween the m a c r o m o l e c u l e s wi th each 
specific l inker a n d side g roups . Pheno th i az ine s h a v e n o 
mutagen ic i ty , bu t have a n t i m u t a g e n i c effects o n bac te -
ria. They have s o m e specificity to cova len t ly c losed 
c i rcular (ccc) f o r m of p lasmid D N A , while open circu-
lar (oc) o r l inear (lin) f o r m s a re less sensit ive [10,11], 
X a n t h i n e ana logs of s o m e elect ron rich accep to r s can 
c o m p e t e wi th the an t ip l a smid ef fec ts of p h e n o t h i a z i n e s 
[7,12], b u t t he molecu la r s t ruc tu re of t a rge t in bac te r i a 
has not been shown clearly. T h e in te rac t ion of p h e n o t h -
iazines wi th guanos ine m o n o n u c l e o t i d e has been de-
scribed [13]. 
It is s u p p o s e d tha t the an t ip l a smid effect of p h e n o t h -
iazines is d u e to an in te rca la t ion or f o r m a t i o n of a 
cha rge t r ans f e r (CT) complex . T h e exact b ind ing t a rge t s 
could n o t be still de t e rmined . T h e ca t ion ic N p a r t o n a 
p h e n o t h i a z i n e l inker a n d negat ive p h o s p h a t e g r o u p 
could m a k e an assoc ia t ion by a h y d r o g e n b o n d . Th i s 
hypo thes i s is s u p p o r t e d by the ca lcu la t ion of the ge-
o m e t r y a n d energies on c h l o r p r o m a z i n e , 2 ' -de-
o x y g u a n o s i n e - 5 ' - m o n o p h o s p h a t e a n d the a d d u c t [14]. 
Add i t iona l ly , a p resence of s tack ing ( in te rac t ion) be-
tween nucleic acid bases and p h e n o t h i a z i n e molecu les 
was a lso suggested [14]. Nucle ic acid bases a n d their 
related a r o m a t i c heterocycles m a y t ake pa r t in s t ack ing 
in te rac t ion w h e n the a r o m a t i c sheets of t w o o r m o r e 
molecules a re placed paral le l to each o t h e r at 3.4 -3 .5 A 
[15], T h e d i f fe ren t molecules have d i f fe ren t s t a c k i n g 
aff ini ty . C o m p o u n d s hav ing m a n y h e t e r o a t o m s wi th the 
po la r b o n d s by d ipole m o m e n t s can have the h ighes t 
abi l i ty to f o r m a s tack ing in te rac t ion . T h e o r d e r of the 
polar iz ing power for s t ack ing in te rac t ion is caf fe ine > 
g u a n i n e > adenine > pu r ine > indole . Simple a r o m a t i c 
c o m p o u n d s with most ly C - C o r C = C bonds , such as 
indole , also have high po la r iz ing abil i ty — with the 
fo l lowing order : indole > aden ine > pu r ine > 
guan ine > caffeine. 
W e rechecked the d e t e r m i n a t i o n of the act ive sites of 
the s tacking in teract ion in p lasmid of bacter ia in the 
presence of pheno th iaz ine . T h e polar iz ing abil i ty of 
pheno th iaz ines could be respons ib le for the biological 
activities. T h e an t ip lasmid ef fec t of p r o m e t h a z i n e was 
s tudied in the presence of ca f fe ine a n d indole respec-
tively. T h e compet i t ive effect of th ree xan th ine ana logs 
(caffeine, indole and G M P ) was tested on the p lasmid 
e l imina t ion effect of p r o m e t h a z i n e in vi t ro to de t e rmine ? 
the specificity. 
2. Mate r i a l s and methods 
2.1. Compounds 
Prome thaz ine and c h l o r p r o m a z i n e were pu rchased 
f r o m E G Y T , Budapes t , H u n g a r y . Ca f f e ine a n d indole 
were purchased f r o m F l u k a a n d R e a n a l . Guanos ine -5 ' -
m o n o p h o s p h a t e ( G M P ) a n d a d e n o s i n e - 5 ' - m o n o p h o s -
p h a t e ( A M P ) were kindly given by Professor H a r r i 
L o n n b e r g f r o m T u r k u Univers i ty (Fig . 1). 
(1) Phenothiazines 
N(CH3)2 
H — C CH3 
I 
(CH2)2 
promethazine 
N(CH3)2 
(CH2)3 
c o o a:crcl 
chlorpromazine 
(2) Xanthines and indole 
O 
NH ( T i 
N N I 
H 
xanthine 
CH, O 
X 1 
I 
CH3 
caffeine 
/ CH, 
O O 
- O - P - O 
o 1 
H O H H H 
o 
NH 
X 
N NH, 
2'-deoxyguanosine 5'-
monophosphate 
0 
- O - P - O 
1 o-
C Ô 
H OH H H 
NH2 
N 
N ' 
2'-deoxyadenosine 5'-
monophosphate 
CO 
indole 
Fig. I Structures of phenothiazines, xanthines and indole. 
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Fig. 2. Ratio of reduction of plasmid elimination by concentrations of 
promethazine at 0, 40, 60, 80 mg/l. 
Fig. 3. Ratio of reduction for plasmid elimination by promethazine 
(60 mg/l) for caffeine, indole and GMP; promethazine and caffeine: 
promethazine and indole; promethazine and G M P . 
2.2. BacteriaI strain 
Escherichia coli K 1 2 LE140 (T 6 r , T,s, S m R , l a c " A . 
S U " , I R , M a C ) . 
2.3. Culture media 
T r y p t o n e - y e a s t ex t rac t ( M T Y ) liquid med ia was 
used fo r the cu l t iva t ion of live cell a n d in the de te rmi-
na t ion of cell coun t s . Eos in -me thy lene blue ( E M B ) agar 
was used for the d i f f e r en t i a t i on of lac negat ive (lac ) 
and lac posi t ive (lac + ) colonies . 
2.4. Methods 
A n overn ight cu l tu re of E. coli K l 2 L E I 4 0 was 
d i lu ted to 1 0 " 4 a n d 0.05 ml a l iquo t s ( a p p r o x i m a t e l y 
5 x 101 cells) was inocula ted into 5.0 ml M T Y b r o t h . 
T h e va r ious concen t r a t i ons of ca f fe ine ( 1 0 - 1 6 3 mg/l ) 
a n d indole ( 6 . 2 5 - 1 0 0 mg/l ) plus p r o m e t h a z i n e in 60 
mg/ l concen t r a t i on were a d d e d , a n d the tubes were 
i ncuba t ed at 37°C for 24 h w i t h o u t shak ing . T w o 
d i lu t ions ( 1 0 " 4 a n d 1 0 " 5 c o n c e n t r a t i o n s ) were pre-
pa red f r o m tubes showing g r o w t h a n d pla ted in 0.1 ml 
a m o u n t s on E M B agar . T h e pla tes were incuba ted a t 
37°C fo r 24 h, then coun ted fo r p ink ( l a c " ) and deep 
violet (lac + ) colonies . T h e pe rcen tage (%) of p lasmid 
e l imina t ion was de te rmined . 
3. Results and discussion 
P r o m e t h a z i n e was effective in the e l imina t ion of plas-
mid in the s tudy (Table 1 and Fig. 2). 
Ca f f e ine significantly reduced the an t ip l a smid effect 
of p r o m e t h a z i n e and the extent of r educ t ion was con-
c e n t r a t i o n - d e p e n d a n t of caf fe ine (Tab le 1 a n d Fig. 3). 
Us ing caf fe ine a lone , the F ' lac p lasmid was not elimi-
na t ed f r o m the bacter ial cells. T h e observed reduc t ion 
by caf fe ine of the p lasmid e l imina t ion act ivi ty of 
p r o m e t h a z i n e suggested a c o m b i n a t i o n effect of two 
c o m p o u n d s . A compe t i t i on be tween caf fe ine a n d some 
physio logica l subs t ra tes which h a v e a s t ruc tu ra l s imilar-
ity could be suggested. These subs t r a t e s m a y be a 
p u r i n e base of D N A , e.g. guanos ine m o n o p h o s p h a t e 
( G M P ) . T h e c o m b i n a t i o n of p r o m e t h a z i n e a n d caf fe ine 
(60; 10) resulted in p lasmid e l imina t ion (Tab le 1 and 
Fig . 3). 
Indo le reduced the effect of p r o m e t h a z i n e slightly, 
d e p e n d i n g on the concen t r a t ion . T h e reduc ing effect by 
G M P was m o r e t h a n tha t of indole (Tab le 1 a n d Fig. 
3). A c o m b i n a t i o n of p r o m e t h a z i n e a n d G M P did no t 
s h o w a significant reduc t ion of p lasmid e l imina t ion by 
p r o m e t h a z i n e , c o m p a r e d to the c o m b i n a t i o n effect with 
caf fe ine . T h e extent of reduc t ion of p lasmid e l imina t ion 
was m o r e similar in the presence of G M P t h a n in the 
presence of indole (Table 1 and Fig. 3). 
A third molecule , one of caf fe ine . G M P a n d indole, 
cou ld influence the complex f o r m a t i o n between 
p r o m e t h a z i n e and plasmid D N A in the fo l lowing ways: 
(i) t he thi rd molecule could f o r m a s t ronge r complex 
wi th p lasmid D N A or with a p r o m e t h a z i n e . T h e three 
c o m p o u n d s of this third molecule w o u l d be the compe t -
ing agen t s agains t p r o m e t h a z i n e in the in te rac t ion with 
p lasmid D N A . (ii) T h e th i rd molecu le could a lso fo rm 
a s t ronger complex with p r o m e t h a z i n e t h a n the plasmid 
D N A . Consequen t ly , the c o n c e n t r a t i o n of free 
p r o m e t h a z i n e would decrease. 
Table 1 
Reduction of plasmid elimination by promethazine alone and combined with caffeine, indole or G M P 
C o m p o u n d Concentrat ion Plasmid elimination (%) Average of plasmid elimination Number of colony Average of number of Rat io (plasmid elimination average/ 
(mg/1) (%) colony 21.2) 
Promethazine 0 0.00 0.00 0.00 0.00 5150 7051 6861 6687 0.00 
40 0.00 1.30 0.50 0.60 2501 3164 1815 2493 0.00 
60 20.30 25.60 18.20 21.20 596 472 509 526 1.00 
80 21.95 19.80 17.10 19.61 103 115 201 140 0.93 
Promethazine 6 0 + 10 22.30 26.06 19.02 22.46 615 423 550 529 1.06 
+ caffeine 
60 + 20 21.80 12.80 14.48 16.12 639 501 504 548 0.76 
60 + 41 6.80 8.30 6.05 7.05 581 403 502 495 0.33 
60 + 82 1.88 3.45 2.33 2.55 565 440 475 493 0.12 
6 0 + 1 6 3 0.05 1.60 0.25 0.63 563 425 490 493 0.03 
Promethazine 60 + 6.25 19.80 24.30 19.05 21.05 513 525 483 507 0.99 
+ indole 
60+12 .50 18.10 25.10 18.52 20.57 581 498 427 430 0.97 
60.25 21.60 22.05 18.03 20.56 576 471 435 494 0.97 
60 i 50 10.50 18.20 13.45 14.05 503 440 455 466 0.66 
6 0 + 100 9.98 6.80 9.30 8.69 598 435 471 501 0.41 
Promethazine 6 0 + 1 0 19.50 20.05 19.10 19.55 610 502 510 541 0.92 
+ G M P 
60 + 20 16.30 18.20 19.76 18.08 575 481 451 502 0.85 
60 + 41 12.10 16.05 10.40 13.40 517 490 466 492 0.63 
60.82 12.50 5.10 9.60 9.07 581 416 413 470 0.43 
6 0 + 163 6.30 3.20 2.30 3.93 566 404 445 472 0.19 
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In the first case, the third molecule has the character-
istics of promethazine. In the second case, the plasmid 
DNA-like compounds reduces the antiplasmid effect of 
promethazine. It was observed that phenothiazines 
could also form some complexes with xanthine dyes, or 
some nucleotides. 
High performance liquid chromatography (HPLC) 
measurement has shown the formation of a charge 
transfer (CT) complex in a chlorpromazine-GMP sys-
tem [16,17]. The chlorpromazine-GMP system has 
non-Newtonian properties in viscosity [16,17], The dif-
ference between Raman spectra of a chlorpromazine-
GMP system predicts an interaction between the 
dimethylaminopropyl group of chlorpromazine and 
phosphate group of GMP [16,17], It can therefore be 
suggested that the stacking interaction is present on a 
complex formation between promethazine and caffeine 
or indole. The interaction of a complex formation 
between promethazine and caffeine is stronger than 
that of a complex formation between promethazine and 
indole. If two interaction types including stacking exist, 
it means that at least two types of interactions are 
present for the complex formation between phenothi-
azines and plasmid D N A . One is an ionic interaction 
between the linker of phenothiazine and phosphate 
group of D N A . The second is a stacking interaction 
between aromatic sites of phenothiazines and nucleic 
acid bases such as guanosine, with a higher affinity than 
that of adenosine. On the basis of the weaker stacking 
interaction, the weaker antiplasmid competition effect 
of adenosine monophosphate (AMP) can be 
understood. 
We concluded that promethazine might form a com-
plex with two guanine-cytosine ( G - C ) rich regions of 
DNA. The native uncomplexed sites of the G - C rich 
regions are necessary for normal plasmid replication. 
Their phenothiazine complexes, however, should not 
maintain the physiological functions of the G - C rich 
regions in the ccc form of plasmid DNA. 
To confirm this hypothesis, we plan to study the 
interaction of phenothiazines and some xanthine dyes, 
which also reduce the antiplasmid effect of phenothiazi-
nes to varying extents. 
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Biological Activity of Kiwifruit Peel Extracts 
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Various bioactive substances in kiwifruit extracts were fractionated by organic solvent extractions, fol-
lowed by silica gel and ODS chromatographies. Both cytotoxic activity and multi-drug resistance reversal 
activity were found in the less polar fractions. Cytotoxic activity was not always parallel the radical 
intensity. Antibacterial activity was distributed into various fractions and all fractions were inactive 
against Candida albicans and H. pylori. Only 70% methanol extracts showed anti-human immunodefi-
ciency virus activity, and produced a broad ESR signal under alkaline conditions, in a fashion similar to 
lignin. These fractions also effectively scavenged 0 2 ~ produced by the xanthine-xanthine oxidase reac-
tion, suggesting a bimodal (pro-oxidant and antioxidant) action. These data suggest a medicinal efficacy 
of kiwifruit peel extracts. Copyright © 2001 John Wiley & Sons. Ltd. 
Keywords: Actinidia deliciosa: Actinidiaceae: kiwifruit peel extracts: fractionation: cytotoxic activity; anti-HIV activity; 
radical intensity. 
INTRODUCTION 
Kiwifruit, Actinidia deliciosa (Actinidiaceae) has been 
mainly cultured in the tropics and subtropics such as New 
Zealand, Chile. France and Japan. Kiwifruits have been 
eaten stewed, in jams, jelly, juice and others. To assess 
the in vitro antioxidant potential of kiwifruit extracts, 
nucleoids are treated in the gel with H 2 0 2 (Collins. 
1999). Consequently, the extracts effectively reduced the 
H202-induced D N A breaks, suggesting its antioxidant 
activity (Collins, 1999). Kiwifruit extracts inhibited the 
adenosine diphosphate (ADP) and coilagen-induced 
platelet activation/aggregation (Dutta-Roy. 1999). Modu-
lation of platelet reactivity towards collagen and ADP by 
kiwifruit extracts may have prophylactic and therapeutic 
benefits in preventing and halting platelet-involved 
pathological processes (Dutta-Roy. 1999). Kiwifruit 
juice efficiently inhibits nitrosation. both in vitro and in 
vivo, possibly by various components such as ascorbic 
acid and other unidentified nitrile scavengers (Puju et a!.. 
1984). Additionally, kiwifruit is rich in ascorbic acid, 
which might affect cell proliferation and DNA svnthesis 
(Bishun et al.. 1978). 
We have investigated the biological activities of botlt 
exhausted and edible components of summerfruits 
(tropica! and subtropical fruits), cacao, grape, feijoa and 
other fruits (Motohashi etui.. 1999: Shirataki eta!.. 2000: 
" Corrcspondincs so: Dr Nofcor.: Mciohasm. Meiji Pharinoccuucai 
University. 2-5:2-1 Noshio. Kivosc. Tokyo 204-S3SS. Japan. 
E-mai!: motonasi(¿ my-pharm.ae.jp 
Om'.fueiAtrmu sponsor: I'otmtlation for O-.r.ccr Re-v.:re!: of Soigcd tSeeyeJ: 
Knkkutataser Alapilvany). Hungary. 
Motohashi et al., 2000). We investigated here the diverse 
biological activity of kiwifruit peel extracts. 
MATERLALS AND METHODS 
Materials. Kiwifruit peels were supplied from New 
Zealand Kiwifruit Marketing Board (ZESPRI). Auck-
land. The following chemicals and reagents were 
obtained from the companies indicated: RPMI1640 
medium. Duioecco's modified Eagle medium (DMEM) 
l Gibco BRL. Grand island. NY): fetal bovine serum (FBS) 
(JRK Bioscience): 3-i4.5-dimethylthiazol-2-\i)-2.5-di-
phenyitetrazolium bromide (MTT) (Wako Pure Chemical 
industries Lid. Osaka): 3'-azido-2',3'-dideoxythymidine 
f.AZT). dideoxycytidine (ddC) (Sigma); dexiran sulphate 
(8 kD) (Kowa. Tokyo): curdlan sulphate (300 kD) 
i.Ajinomoto. Tokvo): diethvlenetriaminepentaacetic acid 
(DETAP.AC) (Sigma Chemical Co.. St Louis. MO): 
3.4-dihydro-2.2-dImethyl-2//-pyrrole- 1-oxide (DMPO) 
(a spin trap agent) (Aldrich Chemical Co. IN. USA): 
superoxide dismutase (SOD) from bovine erythrocytes 
(Dojin. Kumamoto. Japan). A strain of Helicobacter 
pylori I.ATCC43504) was purchased from the American 
Type Culture Collection (Rockville. MD). Human red 
blood ceils f.RBCs) were collected from the heparinized 
•human peripheral blood of normal volunteers. The £. coli 
' - I ' l l i : ¡ . I f ! « . y ! r . , „ / . , . I , , . , ! r r r , ; . l ; r A . T C C 
12228 laboratory test strains were used and Candida 
albicans was a clinical isolate. 
Preparation and fractionation of kiwifruit peel 
extracts. Dried peels of Actinidia deliciosa (2.3 kg) were 
Copyright i; 2001 John Wiley & Sons. Lid. 
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Kiwifruit peel (2.3 kg) 
extracted with hexane 
t) Hexane extracts [KPP-H0| (14.3 g) (10 g) silica gel CC eluted with hexane-acetone 
extracted with acetone 
2) Acetone extracts (KPP-AO) (64.7 g) (10 g) silica gel CC eluted with faenzene-EtOAc 
extracted with MeOH 
3) MeOH extracts [KPP-MO| (868.0 g) (10 g) silica gel CC eluted with CHCI3-MeOH 
extracted with 70% MeOH 
4) 70% MeOH extracts (KPP-70M0) (234.0 g) (10 g) ODS CC eluted with MeOH-HjO 
- H 1 (7.2 g) 
- H2 (0.6 g) 
- H3 (0.5 g) 
- H4 (0.2 g) 
- H 5 (0.2 g) 
-A1 (0.1 g) 
• A2 (0.5 g) 
- A 3 (0.1 g) 
- A 4 (0.3 g) 
- A5 (0.3 g) 
- A6 (1.3 g) 
- M l (0.1 g) 
- M2 (0.1 g) 
- M3 (0.1 g) 
- M4 (0.3 g) 
- M5 (1.1 g) 
- 70M1 (7.7 g) 
- 70M2 (1.5 g) 
- 7 0 M 3 (0.1 g) 
- 70M4 (0.1 g) 
- 70M5 (0.1 g) 
- 70M6 (0.1 g) 
Figure 1. Fractional separation of kiwifruit peel extracts. CC: column chromatography. 
successively extracted with hexane. acetone, MeOH and 
70% MeOH at room temperature and the solvent was 
concentrated in vacuo, and the hexane extract (HO) 
(14.3 g). acetone extract (AO) (64.7 s). MeOH extract 
(MO) (868.0 g) and 707c MeOH "extract (70MO) 
(234.0 g) were obtained, respectively (Fig. 1). First, an 
aliquot of the hexane extract (HO) (10 g) was applied to 
silica gel column chromatography, which was then eluted 
with a hexane-acetone gradient. The hexane fraction 
(HI) (7.2 g), hexane-acetone (9:1) fraction (H2) (0.6 g), 
(H3) (0.5 g), hexane-acetone (4:1) fraction (H4) (0.2 g), 
and hexane-acetone (1:1) fraction (H5) (0.2 g) were 
stepwise eluted. Second, the acetone extract (10 g) was 
applied to silica gel column chromatography, which was 
then eluted with a benzene-EtOAc gradient. The benzene 
fraction (Al) (0.1 g). benzene-EtOAc (9:1) fraction (A2) 
(0.5 g). (A3) (0.1 g) benzene-EtOAc (4:1) fraction (A4) 
(0.3 g). benzene-EtOAc (3:2) fraction (A5.) (0.3 g). and 
benzene:EtOAc (1:1) fraction (A6) (1.3 g) were stepwise 
eluted. Third, the MeOH extract (lOg) was applied to 
silica gel column chromatosraphv. which was then eluted 
with a CHCl-.-MeOH gradient. The CHC1-, fraction (M 1) 
(0.1 g). CHCl-.-MeOH (49:1) fraction (M2) (0.1 s). 
CHCI-.-MeOH (24: H fraction I.M3J (0.1S). C H C h -
MeOH (9:1) fraction (M4) (0.3 g) and CHCl—MeOH 
(4:1) fraction (M5i (1.1 g) were .stepwise eluted. Finally, 
the 70% MeOH extract (10 s) was applied to ODS 
column chromatosraphv. which was then eluted with a 
HiO-MeOH gradient. The H-O-MeOH (2:1) fractions 
(70MJ) (7.7 g). (70.M2) (1.5 s). (70M3) (0.1 s). H , 0 -
MeOH (1:1) fraction (70M4) i5.1 si. (70M5) (Oil s). and 
(70M6) (0.1 gi were stepwise eluted iFis. D. 
Assay for cytotoxic activity. Human oral squamous eel! 
carcinoma ee!B iHSC-Z:. human salivary siar:d tumour 
cells iHSG) and human slnshai fibroblasts iHGF) (5-7 
population doubling ievelsj were cultured in DMEM 
medium supplemented with ll.'H FBS. These cells were 
the concentrations of test samples indicated, and the 
relative viable cell number was then determined by the 
MTT method and expressed as the absorbance at 540 nm 
(A:;»!. The ram cytotoxic concentration (CC?,,) was 
determined from the dose-response curve. 
CYpxrish: F 2(1)1 John V.'iioy X: Son*. Ltd. 
Assay for anti-human immunodeficiency virus (HIV) 
activity. Human T cell leukaemia virus 1 (HTLV1)-
bearing CD4 positive human T cell lines, MT-4 cells, 
were infected with HIV-1 niB at a multiplicity of infection 
(m.o.i.) of 0.01. HI V-, or as a control, mock-infected MT-
4 cells (1.5 x 105/mL. 200 LIL). were placed into 96-well 
microtitre plates and incubated in the presence of various 
concentrations of the test compounds. After incubation 
for 5 days at 37 °C in a 5% C02 incubator, the cell 
viability was quantified by a colorimetric assay (at 
540 nm and 690 nm), monitoring the ability of viable 
cells to reduce MTT to a blue formazan product 
(Nakashima et al.. 1992). All data represent the mean 
values of triplicate measurements (Table 1). The CC50 
and 50% effective concentration (EC5Q) were determined 
from the dose-respon.se curve with mock-infected or 
HIV-infected cells, respectively. The selectivity index 
¡SI) was defined as follows: 5I=CCir/EC5,> 
Antibacterial activity. The experiments were done by 
adding 10.uL aliquots of the original solutions as a 
droplet to the minima! medium supplemented with 1% 
trypton and 0.5% yeast extract iMTY) broth and blood 
agar plates inoculated wit:-. cells of the tested strains 
'Molnár e: a:.. 199Sa<. After incubation for 24 h at 37CC. 
the inhibitory zones in the rlate- were measured. As a 
.:o:irr-">l. i f pi. of DM50 was added to each strain. 
Candida albicans was sensiti'.e to DMSO. whereas £. 
•:c:i and S'annvl, >ct"ca: • cridcnnidis were insensitive 
'Table 3). 
Anii-Helicohacter pylori iH. pylori) activity. Mueller-
Hi n ton broth containing 5% fetal bovine serum (FBS) 
••• a- used as the medium, and was cultured in a jar 
conditioned with Campylo Pack íDia latron) tor 4S h. 
Brie ily. H. ¡^yirri strains were inoculated on a Brucella 
agar pinte containing 10H horse serum, and cultured at 
37 : C for -Sr.. The bacteria! colonies collected were 
diluted to 10 colony forming unit (CFU)/mL with 0.97r 
..!'.: . . . . . :r. ..ion- ai . o l . -d it: DMSO. and the:, 
diluted with Mueller-Hinton broth. To the solution of the 
fractions, a suspension of each bacterium species was 
added to make I0ft CFU/100 mL/well. The mixture was 
incubated at 37°C for 48 h. The MIC (minimum 
inhibitory concentration) values of the fractions tested 
Plr. wilier. Res. 15. 337-343 t200li 
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Table 1. Cytotoxic and anti-HIV activity of kiwifruit peel extracts and fractions 
Cytotoxic activity® (CC50: pg/mL) Anti-HIV activity 
Extract 
and fraction 
Human oral t u m o u r cell line 
HSC-2 HSG 
Human 
gingival 
f ibroblast 
(HGF) 
SI 
(HGF/ 
HSC-2) 
CC50 
(pg/mL) 
ECso 
(pg/mL) 
SI 
(CC50/ 
ECso) 
HO >500 385 >500 > < 1 108 >200 < 1 
H1 >500 446 >500 > < 1 112 >200 < 1 
H2 186 269 277 1 105 >200 < 1 
H3 188 128 150 1 32 >40 < 1 
H4 338 311 299 1 103 >200 < 1 
H5 214 188 207 1 31 >40 < 1 
AO 401 340 >500 >1 123 >200 < 1 
A l >500 >500 >500 > < 1 >200 >200 > < 1 
A2 284 336 306 1 104 >200 < 1 
A3 184 170 190 1 22 >40 < 1 
A4 52 63 141 3 22 >40 < 1 
A5 138 153 156 1 120 >200 < 1 
A6 355 245 >500 1 71 >200 < 1 
M0 >500 >500 >500 > < 1 >200 >200 > < 1 
M1 425 487 >500 >1 192 >200 < 1 
M2 116 111 189 2 =70 >200 < 1 
M3 373 271 480 1 =94 >200 < 1 
M4 >500 >500 >500 > < 1 >200 >200 > < 1 
M5 >500 >500 >500 > < 1 >200 >200 > < 1 
70M0 >500 >500 >500 > < 1 >200 >200 > < 1 
70M1 >500 >500 >500 > < 1 >200 >200 > < 1 
70M2 >500 >500 >500 > < 1 >200 >200 > < 1 
70M3 >500 >500 >500 > < 1 >200 57 > 4 
70M4 >500 >500 >500 > < 1 118 >200 < 1 
70M5 >500 >500 >500 > < 1 >200 34 > 6 
70M6 368 362 392 1 >200 18 >11 
Cell no. (A540) 0.904 0.649 0.281 
Dextran sulphate 636 4.14 154 
Curdlan sulphate >1000 0.72 >1389 
AZT (pM) 276 0.033 8364 
ddC (uM) 475 0.16 2969 
3 Near confluent HSC-2, HSG and HGF cells were incubated for 24 h with various concentrations of KGFP extracts, and the 
relative viable cell number (A5JQ) was determined by the MTT method. The 50% cytotoxic concentration (CC50) was deter-
mined by the dose-response curve. Each value represents the mean of duplicate determinations. Control A5 d 0 values of HSC-
2. HSG and HGF cells were 1.138, 0.804 and 0.507, respectively. 
• ere determined by eye and densitometry measured at 
>20 nm (Numao et al.. 1997: Kawase et c:!.. 1999) 
Table 3). 
Ceil a n d fluorescence up take . The L5! "78 mou.- - T cell 
lymphoma cell line was transfected with a M D R 1 / A 
retrovirus, as previously described (Pastan el a!.. 19SS). 
MDR1 expressing cell lines were selected by culturing 
:::e infected cells with 6 0 n g / m L colchicine to maintain 
expression of the MDR phenotype. The L517S M D R cell 
line, and the L5178Y parent cell line, were grown in 
McCoy ' s 5A medium with 10% heat-inactivated horse 
•erum. L-glutamine and antibiotics. The cells were 
Ujusted to a concentration of 2 • 10'VniL and resus-
yended in serum-free McCoy 's 5A medium and 0.5 mL 
aliquots of the cells were distributed into the Eppendorf 
entrifuge tubes. Then. 2.0 ttL of 2.0 mg/niL of the tested 
usicuv-'iis Vvere audcu auu iiicubatcu t u n i m ... i 
temperature. Then 50 pL Rhodamine 123 (R123) in-
dicator (5.2 pM final concentration) was added and 
incubated for a further 20min at 37 °C. Af ter washing 
twice and ¡¿suspending in 0.5 mL phosphate-buffered 
Cop> right I 2001 John Wiley & Sons. Ltd. 
saline (PBS), the fluorescence of the cell population was 
measured by flow cytometry, using a Beckton Dickinson 
FACScan instrument (cell sorter). Verapamil was used as 
a positive control in the R123 accumulation experiments 
• Weaver ?t al.. 1993). The R123 accumulation was 
calculated from the fluorescence intensity of the samples. 
The percentage of the control of the untreated mean 
fluorescence intensity was calculated for the parental and 
MDR cell lines and compared with the fluorescence 
intensity of the treated cells. An activity ratio was 
calculated bv the following equation (Kessel. 1989: 
Weaver et al.. 1993) (Table 3) 
MDR reversal activity = 
(MDR treated/MDR control) 
(parental treated/parental control) 
Assay for radical intensi ty. Radical intensity was 
determined at 25°C using electron spin resonance 
Phytother. Res. 15. 337-343 (2001) 
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Table 2. Radical modulation effect of kiwifruit peel extracts and fractions 
Extract 
and f ract ion 
Radical intensi ty of s o d i u m ascorbate (3 mM) (at pH 8.0)a 
Ho Qrf lupnninn i4Pti\/it\/ 
0 0.003 0.03 0.33 3 m g / m L 
w2 ocavci 'y ' ' 'y acuvi iy 
(SOD un i t /mg) 
HO 0.46b 0.44 0.53 0.58 1.40 0.85 
H1 0.40 ' 0.44 0.66 0.78 1.60 0.70 
H2 0.46 0.45 0.47 0.59 1.26 0.90 
H3 0.42 0.44 0.51 0.50 1.16 0.73 
H4 0.44 0.54 0.39 0.68 1.21 0.98 
H5 0.44 0.42 0.39 0.55 1.25 0.99 
AO 0.44 0.36 0.34 0.35 0.77 13.66 
A l 0.48 0.46 0.50 0.49 0.59 0.20 
A2 0.44 0.46 0.55 0.80 1.92 0.72 
A3 0.44 0.47 0.44 0.50 1.20 0.99 
A4 0.42 0.44 0.46 0.89 2.09 N.D.C 
A5 0.44 0.39 0.41 0.55 1.34 8.28 
A6 0.45 . 0.38 0.59 0.62 1.03 29.96 
M0 0.50 0.46 0.44 0.33 0.49 4.14 
M 1 0.49 0.50 0.49 0.54 0.95 1.97 
M 2 0.45 0.42 0.65 1.04 2.44 1.15 
M3 0.45 0.43 0.56 0.96 1.48 4.51 
M 4 0.47 0.46 0.43 0.69 1.20 25.94 
M5 '0.50 0.43 0.43 0.54 0.72 16.73 
70M0 0.48 0.37 0.34 0.35 0.67 3.76 
70M1 0.44 0.43 0.39 0.37 0.51 2.52 
70M2 0.46 0.40 0.36 0.36 0.69 5.74 
70M3 0.47 0.40 0.51 1.19 2.49 18.92 
70M4 0.47 0.45 0.95 1.90 3.08 48.36 
70M5 0.48 0.36 0.46 0.90 1.98 17.95 
70M6 0.45 0.46 0.43 0.95 1.89 6.23 
a Radical intensi ty of s o d i u m ascorbate (3 mM) in the presence of 0 -3 m g / m L each fract ion in 0.1 M Tris-HCI, pH 8.0. 
b Each value represents the m e a n of t r ip l icate de te rmina t ions . 
c N.D. not detected. 
(ESR) spectroscopy ( J E O L JES R E I X , X-band. 100 kHz 
modulat ion f requency) . Instrument settings: centre field. 
335.6 ± 5.0 mT: mic rowave power, 8 m W : modulat ion 
ampli tude, 0.1 mT: gain. 630: time constant . 0.1 s: 
scanning time, 4 min. Radical intensity was determined 
in 0. 1M Tris-HCI (buf fe r pH 8.0) in the presence of 3 m.M 
sodium ascorbate containing 509c D.MSO and the radical 
intensity was defined as the ratio of peak heights of these 
radicals to that of M n O (Satoh ei al.. 1997) (Fig. 2). 
Rad ica l scavenging ac t iv i ty a g a i n s t s u p e r o x i d e anion 
| 0 2 " ) . was generated by hvpoxanthine (HX) and 
HO , AO MO 70M0 
HI 
-tv 
t I i 
\ , A l . Ml 70M1 
H2 
' 'i 
, . A2 M2 , 70.M2 
H3 
j i 
, v A3 
t 
. , M 3 , 70M3 
H4 . ^ A4 
i 1 
M4 
1 
[j . , 70M4 
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 A 5 . b i MS 
} ' ' 
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nO 
• , n 
l J5j MnO MnO 
¡ i 
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Mr. O MnO 
70M6 
i i 
MnO 1 mT MnO 
Figure 2. ESR spectra of 26 k iw i f ru i t peel extracts and fract ions (3 m g / m L ) 
m e a s u r e d 1 min after d isso lv ing in 0.1M NaHC03/Na 2C0 3 , pH 10.5. The gain in 
A5 w a s changed to 100. 
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Table 3. Antimicrobial activity of kiwifruit peel extracts and fractions" 
Gram-posit ive Gram-negative Fungi (Candida) H. pylori 
Extract Staphylococcus epidermidis Escherichia coli Candida albicans MIC 
and fraction ATCC 12228 K12LE140 (cultivated on MTY agar) (pg/mL)e 
HO - f NDb 
HI — ± - >100 
H2 + +c - >100 
H3 — ± - >100 
H4 _ ± - >100 
H5 - ± - >100 
AO + — ND 
A1 — - - >100 
A2 — - — >100 
A3 — + - >100 
A4 — - - >100 
A5 — — — >100 
A6 + - >100 
M0 — _ — ND 
M1 — — - >100 
M2 _d - - >100 
M3 — - - >100 
M4 ; — + - >100 
M5 - - - >100 
70M0 — _ — ND 
70M1 - - - >100 
70M2 — ++ — >100 
70M3 - — - >100 
70M4 — - - >100 
70M5 — T- — >100 
70M6 - + + - >100 
Metronidazole _ _ — 74.0 
Clarithromycin S9 Rh - 1.9 
Erythromycin S R - 1.8 
DMSO (control) - - — 
a + + , Complete growth inhibit ion on the surface of inoculated agar plates; -f, growth inhibit ion but a few resistant colonies 
started to develop; ± , some growth inhibitions but majority of the cells were not sensitive; ineffective. 
b ND: not detected. 
" Brown precipitation. 
b Inhibition of haemolysis. 
a The MIC value was determined for each extract and fraction by a broth microdilut ion method using H. pylori IATCC43504 
(Numao eta!., 1997; Kawase et al., 1999). 
: Positive control fluconazol. 
q S; Gram-positive St. epldermidis was sensitive to erythromycin and clarithromycin. 
n P.: Gram-negative E. coli was resistant to both erythromycin and clarithromycin. 
xanthine oxidase ( X O D ) react ion (total volume: 200 l i L i 
, 2 m.M HX in phosphate buf fe r i PB) (pH 7.8) 50 uL. 0.5 m.M 
D E T A P A C 20 uL, D M P O 10 u L . ' s a m p l e lin D M S O ) 
50 pL. LOO or S O D 30 pL . X O D (0.5 U / m L In P B ; 
40 uL], The scanning time was changed to 2 min. The 
radical intensity was determined by electron spin resonance 
GSR1 spectroscopy for 1 min. 0 2 ~ scavenging activity wa> 
expressed as SOD unit/nag sample, bv calibration with 
standard curve of S O D (Sakagami et aL 1999). 
The relat ive cy to tox ic act ivi ty of the>e f rac t ions was 
the same, r e sa rd l e s s of the target cells, e i ther HSC-2. 
HSG. H G F o r M T - 4 cel ls (Table 1). T h e cytotoxic 
activity w a s c o n c e n t r a t e d by silica gc! ch roma tog raphy , 
and f ract ions o f hexane ( H 2 . H3) , acetone (A3 . A4. A5) 
and methanol ( M 2 ) ex t rac ts showed high cytotoxic 
activity. H o w e v e r , these f rac t ions except A 4 and M 2 
( S l = 2 - 3 ) did not show any specific cyto toxic activity 
against t u m o u r cel ls ( H S C - 2 . H S G ) compared with 
normal ( H G F ) cells (Tab le 1). 
R E S U L T S 
Cy to tox ic ac t iv i ty a n d r a d i c a l i n t ens i ty 
i • — 1 MlOV. -V liiai. U1C <.y / C tw , , U, 
extracts, f rac t iona ted as desc r ibed in Fig. 1. dec reased 
with the increase in polar i ty . T h e 70<T methano l ext ract 
widi the highest water - so lub i l i ty showed the lowes t 
cytotoxic activity. 
Cop> right I 2001 John Wiley & Sons. Ltd. 
R a d i c a l i n t e n s i t y 
ESR spectroscopy showed that only selected fractions (A5, 
whereas other f ract ions including all five hexane fractions 
produced no detectable amounts of radical. This indicates 
that the cytotoxic activity of kiwifruit extracts does not 
always parallel their radical intensity. 
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Table 4. MDR reversion by kiwifruit peel extracts and fractions in lymphoma-5178 cells 
Side scatter 
Forward scatter count (SSC) Fluorescence one 
Extract Concentration count (FSC) (granulation of height Fluorescence 
and fraction (pg/mL in DMSO) (cell size ratio) cell ratio) (FL-1)a activity ratio6 
Par(control)c 10 394 131 4104.0 78.77 
MDR+R123(mean)d 10 413 142 52.1 1.00 
(±) Verapamil (positive centrol) 10 415 110 842.0 16.16 
HO 200 532 174 128 2.09 
H I 200 487 160 92 1.51 
H2 200 584 177 199 3.25 
H3 200 482 230 420 6.89 
H4 200 435 304 977 16.01 
20 452 266 767 5.52 
H5 200 430 295 1165 19.09 
20 398 217 473 3.40 
AO 200 332 116 112 1.31 
A I 200 334 106 68 0.79 
A2 200 322 132 119 1.39 
A3 200 380 84 536 6.24 
A4 200 380 147 1193 13.90 
20 461 188 406 2.92 
A5 200 269 166 75 0.89 
A6 200 363 143 101 1.17 
M0 200 458 156 95 1.56 
M1 200 482 149 103 1.69 
M2 200 503 204 1040 17.05 
20 511 205 427 3.07 
M3 200 460 198 264 4.32 
M4 200 498 142 77 1.26 
M5 200 465 155 55 0.89 
70M0 20 416 120 82 0.79 
70M1 20 417 123 72 0.69 
70M2 20 468 103 72 0.69 
70M3 20 422 104 70 0.67 
70M4 20 486 111 56 0.54 
70M5 20 416 125 106 1.02 
70M6 20 405 111 107 1.03 
a Kessel 1989; Weaver et at., 1993. x 
b The R-123 accumulation was calculated from fluorescence of one height value using equation: log y'• = l o g ! 0 — ; then the 
fluorescence activity ratios were calculated according to the formula given below 2 0 0 
, . . (MDR treated/MDR control.' 
MDR reversal activity = • 
(parental treated/parental control; 
c Par: a parental cell without MDR gene. 
c MDR: a parental cell with MDR gene. 
Table 2 shows that millimolar concentrations of ai! 
fractions enhanced, the radical imensity of sodium 
ascorbate. suggesting its prooxidant action. These frac-
tions also scavenged CF -. generated by the xanthine-
xanthine oxidase reaction, and its scavenging activity 
was roughly increased with the increase in the water 
solubility (Table 2). It is interesting to note that radica! 
producing Tractions (A5, A6. M4," M5, 70M2. 70M3. 
70M-J. 70M5. 70M6) (Fie. 2) most efficiently sea venced 
0-~" (Table 2). 
Anti-HIV activity 
/•xii iicxane (Hi-irip). acetone (A1-A6) and methanol 
fractions (M1-M5) did not protect the MT-4 cells from 
HIV-induced cytopathic effects (SI < 1) (Table I). On 
the other hand, 70% methanol fractions with increased 
water-solubility (70M3, 70M5, 70M6) showed some 
Copyright <" 2001 John Wiley & Sons. Ltd. 
anti-HIY activity i5i = 4 - ! l - iTabic 1). ami produced 
broad i£SR peaks under alkaline conditions ¡Fig. 2). 
Antimicrobial activity 
Only one fraction of hexane extract (H2) partially 
inhibited the growth of Staphylococcus epidennidis. A 
MeOH fraction M2 inhibited the haemolysis of Staphy-
lococcus epidennidis. possibly by the stabilization of red 
blood cell (RBC) membranes or due to other structural 
changes in RBCs. or the efflux of bacterial hemolysine 
could be inhibited (Table 2). 
T\vo ~nr:- mesh« vw (7(V\P. 70S":. 
tely inhibited the growth of E. coli (Table 3). Four 
fractions AO, A3, A6 and M4 moderately inhibited the 
growth of E. coli. Of the antibiotics, clarythromycin and 
erythromycin were used as positive controls (Table 3). 
All 26 kiwifruit fractions were inactive against Candida 
Phytolher. Res. 15. 337-343 (2001) 
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albicans, in contrast to difiucan as the positive control 
(Table 3). All 26 fractions were inactive against H. 
pylori, whereas metronidazole, clarithromycin and ery-
thromycin were effective (Table 3). 
Reversal of multi-drug resistance (MDR) 
Four fractions, H4 (ratio 16.01), H5 (ratio 19.09), A4 
(ratio 13.90) and M2 (ratio 17.05) comparably reversed 
the MDR activity of lymphoma-5178 cells. (±)Verapa-
mil (ratio 16.16) (positive control), H3 (ratio 6.89) and 
A3 (ratio 6.24) were also effective (Table 4). These active 
fractions showed the dose-dependent effect, and their 
effects were still higher than that of 70% methanol 
extracts even at 20 pg/mL (Table 4). 
DISCUSSION 
The present study demonstrates that kiwifruit extracts 
contain various bioactive materials. Fractionation with 
organic solvents and silica gel or ODS column chroma-
tographies separated these activities into various frac-
tions (Table 1). 
Both cytotoxic activity (Table 1) and MDR reversal 
activity (Table 4) were found in the same fractions of 
hcxane (114, H5), acetone (A4) and methanol fractions 
(M4). The biological activity of P glycoprotein (P gp) 
might be responsible for the multidrug resistance (MDR), 
therefore, the reversal effects of kiwifruit extracts and 
fractions can be based on the modification of this 
transmembrane efflux pump (Molnár et al., 1998b). 
However, further purification of these substances is 
required to confirm that these are identical to each other. 
Antibacterial activity was detected in various extracts 
and fractions, and all extracts and fractions were inactive 
against Candida albicans and H. pylori. Only 70% 
methanol fractions showed anti-HIV activity, and these 
fractions produced a broad ESR signal, enhanced the 
ascorbate radical intensity, and scavenged 0 2 ~ , in a 
similar fashion to lignin (Satoh et al., 1996), which 
showed a comparable magnitude in these activities 
(Sakagami et al., 1999). We also found that the radical 
generation roughly paralleled the 0 2 ~ scavenging 
activity, supporting the fact that many plant extracts 
have bimodal (prooxidant and antioxidant) actions. It 
remains to investigate further whether the same molecule 
can switch from prooxidant action to antioxidant action, 
and vice versa. The present study suggests the medicinal 
importance of kiwifruit extracts. 
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Abstract 
The antimicrobial effects of 30 trifluoromethyl ketones [1 30] were studied on various representative bacteria. Of the ketones, 
4,4,4-trifluoro-l-phenyl-l,3-butanedione [10], l,l,l-trifluoro-3-(4,5-dimethyloxazol-2-yl)-2-propanone [11] and l-(2-benzoxazolyl)-
3,3,3-trifluoro-2-propanone [18] were found to exhibit potent antibacterial activity against the Gram-positive Bacillus megaterium 
and Corynebacterium michiganese, but not against Gram-negative bacteria such as Pseudomonas aeruginosa and Serratia 
marcescens. Compounds I I and 18 inhibited the Escherichia coli. Compound 18 was also effective against yeasts. The combination 
of promethazine with 18 was significantly synergistic against E. coli strains, especially the proton pump deficient mutant. The 
results suggest that membrane transporters are the target of trifluoromethyl ketones. The inhibition was more marked in the 
proton pump deficient E. coli mutant than in the wild type, which suggested that the antibacterial effect of trifluoromethyl ketones 
is partly prevented by the proton pump system. © 2001 Elsevier Science B.V. and International Society of Chemotherapy. All 
rights reserved. 
Keywords: Trifluoromethyl ketone; Promethazine; Antibacterial; Synergism; Anti-HlV 
1. Introduction 
T h e widespread use of ant ib io t ics ha s inevi tably re-
sul ted in an increas ing bacter ial resis tance t o exist ing 
d r u g s which th rea t ens publ ic heal th [1,2]. T h e r e is an 
u rgen t need for the discovery of new an t ibac te r i a l c o m -
p o u n d s , possibly ac t ing t h r o u g h m e c h a n i s m s d i f fe ren t 
f r o m those of exist ing d rugs [3,4], 
T r i f l uo rome thy l ke tones ( T F M K s ) a re va luab le 
^Corresponding author. Tel.: + 81-492-862233x455: fax: +81-
492-717984. 
E-mail address: kawasema@josai.ac.jp (M. Kawase). 
c o m p o u n d s wi th b o t h syn the t i c a n d biological interests 
because of the u n i q u e physical a n d biological proper t ies 
impa r t ed by fluorines. T F M K s a re po ten t inhibi tors of 
serine esterases, juveni le h o r m o n e esterase, m a m m a l i a n 
ca rbony l es terases and a n t e n n a l es terases in insects [5]. 
Pept idyl t r i f luoromethy l ke tones have ant iv i ra l activity 
t h r o u g h inhibi t ion of H I V - 1 p ro t ease [6] a n d h u m a n 
cy tomega lov i rus p ro t ease [7], 
T h e deve lopment of new synthe t ic m e t h o d s and the 
biological activity of T F M K s h a v e been s tudied [8,9], 
He re we repor t the an t imic rob ia l activity of s t ructura l ly 
related T F M K s agains t several G r a m - p o s i t i v e and 
G r a m - n e g a t i v e bac ter ia , yeas ts a n d filamentous fungi 
0924-8579/01 /$20 C 2001 Elsevier Science B.V. and International Society of Chemotherapy. All rights reserved. 
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and human immunodeficiency virus (HIV). Among 
thirty TFMKs, five active compounds [5, 10, 11, 18, 
and 20] were studied in detail for the interaction with 
the ATP-binding cassette (ABC) transporter inhibitor 
promethazine by the chequerboard method. 
2. Materials and methods 
2.1. Compounds 
Compound 6 was obtained by the trifluoroacetyla-
tion of 2-lithiobenzoxazole, generated by lithiation of 
benzoxazole with lithium diisopropylamide (LDA), 
with ethyl trifluoroacetate. Five pompounds [11, 14 and 
18-20] were synthesized by treatment of the corre-
sponding methyl-substituted azines with trifluoroacetic 
anhydride in the presence of pyridine [10]. Compound 
12 was obtained in a 71% yield by the oxidation of 
V-butoxycarbonyl-3-trifluoroacetyl-4,5-dihydropyrrole 
with 2,3-dichloro-5,6-dicyano-l,4-benzoquinone (DDQ) 
[11]. Compound 13 was obtained from the reaction of 
mesoionic 4-trifluoroacetyl-3-methyl-2-phenyl-1,3-oxa-
zolium-5-olate and formamidine [9]. Three compounds 
[15-17] were obtained by the trifluoroacetylation of the 
corresponding dimethylaminopyridine with trifl-
uoroacetic anhydride [12], Two compounds [21 and 22] 
were synthesized by the reactions of mandelic acid or 
3-phenyllactic acid with trifluoroacetic anhydride [13]. 
Two compounds [23 and 24] were prepared by treat-
ment of the corresponding JV-alkyl-W-acyl-ot-amino 
acids with trifluoroacetic anhydride [14], Compound 25 
(mp 81 -84 °C) was obtained in 91% yield by the 
catalytic reduction of W-(2,6-dichlorobenzoyl)-2-trifl-
uoroacetylpyrrolidine [15], Compound 26 was obtained 
by the Dakin-West reaction of JV-benzyloxycarbonyl-
1,2,3,4-tetrahydroisoquinoline-l-carboxylic acid with 
trifluoroacetic anhydride [16]. Three compounds [28-
30] were prepared by the reaction of JV-alkoxycarbonyl-
prolines with trifluoroacetic anhydride [11], The other 
ten compounds [1-5 , 7 - 1 0 and 27] are commercially 
available. Details of other substances are: 3'-azido-2',3'-
dideoxythymidine (AZT), dextran sulphate (DS) (8 
kDa) (Kowa, Tokyo), curdlan sulphate (CRDS) (300 
kDa) (Ajinomoto, Tokyo), dideoxycytidine (ddC) 
(Sigma, St. Louis, MO). 
2.2. Organisms used 
Bacillus megaterium (NCAIMB 01208). Covynebac-
terium michiganese 0016, Pseudomonas aeruginosa, Ser-
ratia marcescens, Saecliaromyces cerevisiae, Candida 
albicans, Aspergillus niger 0050, Fusarium maniliforme 
0040 and Escherichia coli AG 100 (wild type) and AG 
100A (its proton pump mutant) were obtained from 
Professor Nikaido (Dept. Molecular and Cell Biology, 
University of California) [17]. 
2.3. Measurement of antibacterial activity 
The antibacterial activity was assayed by adding 10 
pi of stock solutions as a droplet on a minimal medium 
supplemented with 1% tryptone and 0.5% yeast extract 
(MTE) broth and blood agar plates inoculated with 10s 
cells of the tested strains. The plates were incubated at 
37 °C for 24 h after which the inhibitory zones were 
measured. As a control, 10 pi of DMSO was added to 
each strain. It was found that P. aeruginosa was moder-
ately sensitive to DMSO. The growth of E. coli was not 
inhibited by DMSO. An ampicillin disc was used as 
positive control in the studies of antibacterial effects. 
The combined effects of TFMKs were also deter-
mined by the chequerboard dilution technique for 
derivation of the fractional inhibitory concentration 
(FIC) indices and the MIC, according to Ellion et al. 
[18] and Eliopoulos et al. [19]. 
2.4. Measurement of antifungal activity 
The agar medium (1% glucose, 0.25% peptone, 0.25% 
yeast extract, 0.5% maltose extract and 2.0% agar, pH 
7.0) were supplemented with compounds ( 0 - 5 0 pg/ml) 
and poured into Petri dishes. After setting, the plates 
were inoculated with the suspension of microorganisms 
and the samples were incubated at 30 °C for 48 h. 
2.5. Assay for anti-HIV activity 
The inhibition of HIV-induced cytopathic effects by 
TFMKs was studied. Human T cell leukemia virus 1 
(HTLVl)-bearing CD4 positive human T cell lines 
(MT-4 cells), were infected with HIV-1 ¡uu at a multi-
plicity of infection (m.o.i.) of 0.01. HIV- or mock-in-
fected MT-4 cells (1.5 x 105/ml, 200 pi) were placed 
into 96-well microtitre plates in RPMI 1640 medium 
supplemented with 10% heat-inactivated foetal calf 
serum (FCS) and incubated in the presence of varying 
concentrations of the compounds under test. 
After incubation for 5 days at 37 °C in a humidified 
5% C 0 2 incubator, cell viability was quantified by a 
colorimetric assay (at 540 and 690 nm), by monitoring 
the ability of viable cells to reduce 3-(4,5-dimethylthia-
zol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) to a 
blue formazan product [20]. All data represent the 
mean values of triplicate measurements. 
3. Results and discussion 
3.1. Antimicrobial activity 
Thirty TFMKs were tested against the panel of mi-
croorganisms (Fig. 1). Three compounds [10, 11 and 18] 
were found to exhibit potent antibacterial activity 
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Fig. 1. Structure of trifluoromethyl ketones (TFMKs) [1-30], 
agains t B. megaterium and C. michiganese in aga r d i f fu -
sion m e t h o d . C o m p o u n d 18 was a lso act ive aga ins t the 
yeast . O t h e r T F M K s [ 1 - 9 , 1 2 - 1 7 a n d 1 9 - 3 0 ] were no t 
act ive aga ins t any bac ter ia at 2 m g / m l . C o m p o u n d s 10, 
11 a n d 18 t ha t showed initial an t ibac te r i a l act ivi ty were 
used to de t e rmine their m i n i m u m inh ib i to ry c o n c e n t r a -
t ion ( M I C ) values using an a g a r d i f fu s ion assay (Tab le 
1). T h e M I C values of 10 a n d 11 ( M I C : 1 2 - 5 0 pg/ml) 
for B. megaterium a n d C. michiganase, were m u c h 
higher t h a n tha t of 18 ( M I C : 6 pg /ml) . Similar ly, 
c o m p o u n d 18 was a lso m o r e act ive aga ins t the yeasts , 
c o m p a r e d wi th c o m p o u n d s 10 o r 11 (Tab le 1). T h e 
M I C values of 5, 10. 11 and 1 8 - 2 0 aga ins t E. coli were 
also de t e rmined in a b ro th d i lu t ion assay (Tab le 2) a n d 
it was f o u n d tha t the p r o t o n p u m p deficient s t ra in was 
m o r e sensit ive t h a n the wild type . 
3.2. Evaluation of combined effect 
Because of the r e m a r k a b l e an t im ic rob i a l act ivi ty ex-
hibi ted by some T F M K s , a f u r t h e r s t udy was unde r -
t aken to de te rmine the c o m b i n e d ef fec ts of T F M K s 
with p r o m e t h a z i n e which is a po t en t H , - h i s t a m i n e re-
cep to r an t agon i s t of long d u r a t i o n a n d wi th weak 
neuro lep t i c activity. P r o m e t h a z i n e w a s act ive aga ins t 
va r ious bac ter ia , especially G r a m - p o s i t i v e s [21-23] , 
T h e c o m b i n a t i o n of p r o m e t h a z i n e wi th ampici l l in , te-
t racycl ine a n d gentamic in was s ignif icant ly synergist ic 
b o t h in vi t ro and in vivo [24-26] , A high degree of 
synergism was also f o u n d when p r o m e t h a z i n e w a s used 
in c o m b i n a t i o n with methd i laz ine o r b r o m o d i p h e n h y -
d r a m i n e [27,28], 
T h e combined ef fec ts of each T F M K [5, 10, 11, 18 o r 
20] with p r o m e t h a z i n e were de te rmined by the agar 
d i f fus ion and c h e q u e r b o a r d t echn ique fo r de r iva t ion of 
the f rac t iona l inh ib i to ry c o n c e n t r a t i o n ( F I C ) indices 
[18]. F o r q u a n t i t a t i o n of synergism, the F I C indices fo r 
b o t h c o m b i n a t i o n s were calcula ted as descr ibed by 
E l iopou los et al. [19]. T h u s , the F I C index was inter-
pre ted as fol lows: < 0 . 5 , synergy; > 0 . 5 - 1 . 0 , addi t ive 
effects; > 1 .0 -4 .0 , indif ference; and > 4.0, a n t a g o n i s m . 
T h e synergy in c h e q u e r b o a r d tes t ing resul ts for some 
T F M K s and p r o m e t h a z i n e aga ins t E. coli a re shown in 
Tab l e 3. T h e mos t m a r k e d and clear-cut synergism was 
exhibi ted by the c o m b i n a t i o n of 18 with p r o m e t h a z i n e 
in the p r o t o n p u m p express ing E. coli s t ra in . C o m -
p o u n d 11 also showed m o d e r a t e synergy. 
3.3. Anti-HIV activity 
There was n o s ignif icant inhibi t ion by a n y of the 30 
T F M K s of the c y t o p a t h i c effects of H I V infect ion in 
Table 1 
MICs (mg-1) of some T F M K s for Gram-positive bacteria and yeasts 
Compound Microorganism" 
B.M CM SC CA 
10 25 12 > 5 0 > 5 0 
11 > 5 0 > 5 0 > 5 0 > 5 0 
18 6 6 6 12 
° B.M. B. megaterium NCAIM B 01208; CM, C. michiganese 0016: 
SC, S. cerevisiae; CA, C. albicans. 
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Table 2 
MIC values of some T F M K s for E. coli AG 100 (wild type) and E. 
coli AG 100A (mutant) bacteria strains 
Compound MIC mg/1 
E. coli AG 100 (wild) E. coli AG 100A (mutant) 
5 1250 39.1 
10 <9 .8 < 9 . 8 
11 62.5 31.25 
18 7.8 3.9 
19 1250 312.5 
20 1250 1250 
The average count of bacteria were: E. coli AG 100: 1910 CFU/50 pi 
(3.8 x 104 CFU/ml); E. coli AG 100A: 1555 CFU/50 pi (3.1 x I04 
CFU/ml) . 
M T 4 cells us ing effect ive c o n c e n t r a t i o n s of > 500 
mg/1 (Selectivity Index (SI) < 1), c o m p a r e d with the 
f o u r posi t ive c o n t r o l s — dex t r an su lpha te (SI > 453), 
c u r d l a m su lpha t e (SI > 7830), A Z T (SI = 5118) and 
d d C (SI = 174). 
3.4. Cytotoxic activities 
T h e cy to tox ic c o n c e n t r a t i o n (CC 5 0 ) aga ins t M T 4 
m o c k infected cells var ied grea t ly (Table 4); values of 
18, 11, or 10 were cor re la ted to their an t ibac te r ia l 
activity. T h e m e c h a n i s m fo r this is no t k n o w n . 
4. Conclusion 
T h e an t ibac te r i a l activit ies of thir ty T F M K s were 
tested t o scan fo r possible lead s t ruc tures bea r ing a 
t r i f luoroacetyl g r o u p . T h e c o m p o u n d exhib i t ing the 
highest po t ency was 2 - t r i f luoroace tony lbenzoxazo le 
[18]. R e m o v a l of the methy lene of 18, t h a t is 6, 
deleted the po tency . T h e rep lacement of the benzoxa -
zole residue of 18 with o the r a r o m a t i c or h e t e r o a r o -
mat i c rings resul ted in significantly d imin ished 
po tency , ind ica t ing tha t the benzazole der ivat ives were 
m o r e act ive t h a n ei ther benzene or azole der ivat ives . 
Table 3 
MICs (mg/1) of the combination of 11 or 18 with promethazine (PM) 
Compound MIC mg 1 
E. coli AG 100 (wild) E. coli AG 100A (mutant) 
P M 156.25 78.15 
11 62.5 31.25 
PM + 11 39.05+15.65 19.55 + 7.8 
FIC index 0.5 (additive) 0.5 (additive) 
18 0.8 
PM + 18 39 .05+1.0 19.55+1.0 
FIC index 0.4 (synergy) 0.5 (additive) 
Table 4 
Cytotoxic concentrations of T F M K s against mock-infected T4 cells 
Compound CC 5 0 (mg/l)a 
1 > 5 0 0 
2 7 
3 > 5 0 0 
4 268 
5 40 
6 180 
7 > 5 0 0 
8 3 
9 2 
10 4 
11 0.4 
12 > 5 0 0 
13 476 
14 64 
15 239 
16 324 
17 51 
18 0.2 
19 6 
20 10 
21 2 
22 10 
23 240 
24 10 
25 264 
26 67 
27 0.003 
28 263 
29 3 
30 250 
C R D S >1000 
DS >1000 
A7.T (pM) 10.1 
ddC (pM) 83.9 
a 50% cytotoxic concentration (CC5 0) against mock-infected cells. 
These d a t a suggest the benzoxazo le moie ty is of great 
i m p o r t a n c e fo r the an t ibac te r ia l act ivi ty. T h u s , com-
p o u n d 18 showed highly p r o m i s i n g activi ty against 
bacter ia . A fu r the r inves t igat ion of s t r u c t u r e - a c t -
ivity re la t ionship , inc luding the kil l ing m e c h a n i s m of 
the bacter ic idal activity of c o m p o u n d 18, a r e under 
way. 
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Abstract 
T w o 3-benzazepines ([5], [10]) were able to form complex with replicati.ve form of 
plasmid DNA. The multidrug resistance {mdr) P-glycoprotein efflux pump of mouse 
lymphoma cells was inhibited by three compounds ([5], [8], [10]). The inhibitory effects of 
compounds on reverse transcriptase (RT) of Moloney leukaemia had shown a great variety, 
however , the most effective compounds were [7], [8] and [9], 
Introduction 
Antibiot ic res is tance of bacter ia is encoded by e x t r a c h r o m o s o m a l 
D N A , called plasmids . T h e r e are p lasmids encod ing A T P b ind ing cas se t t e 
( A B C ) t ransporter protein which have a great extent of s imilar i ty with a P-
glycoprotein (P-gp) respons ib le for mul t id rug res is tance {mdr) of c a n c e r 
cells (Endicott and Ling, 1989). T h e e m e r g i n g drug res is tance is k n o w n 
Abbreviations: 7.8-Dimethoxy-2-methyl-3-methanesulfonyl-2.3.4.5-teirahydro-3-ben.zazepin-1 -tine ¡1 ]. 
7.8-dimethox)-2-methyl-3-trifluoromeihanesulfonyl-2.3.4.5-tetrahydru-3-benzazepin-1 -one [2], 3-
injluoromeihanesu!fonyl-2.3.4.5-tetrahydro-3-benzazepin-l-one [3], 7.8-dimethoxy-3-trifluoro-
methanesulfonyl-2.3.4.5-tetrahydro-3-benzazepin-l-one [4], 7.8-dime lhaxy-2- ¡sop ropy 1-3-triflu oro-
mé thanesulfor.y I-2.3.4.5-tetrahydro-3-benzazepin-l -one [5], 7.8-dime thoxy-2-phenyl-3-trifluort >-
meihanesulft>r,yl-2.3.4.5-ietrahydro-3-benzazepin-l-one [6], 7 . 8 - d i h y d r o x y - 2 - t r i f i u o r o m e t h x l - 2 . 3 . 4 . 5 -
tetrahydro-1 H-3-benzazepine [7], 7.8-dihydroxy-3-methyl-2-trijlunromethyl-2.3.4.5-tetruhxdro-lH-3-
benzazepine [8], 7.8-dihydroxy-2.3.4.5-tetrahydro-l H-3-benzazepine [9], 7.8-dimethoxy-2-
triflu(>romeih\i-2.3.4.5-teirahydro-lH-3-benzazepine [10], dopamine [DA. ]]]; norepinephrine [NE. 
12]. 
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among viruses, bacteria, protozoa and cancer cells including drug resistant 
retroviruses such as human immunodeficiency virus (HIV) (Hamada and 
Tsuruo, 1986; Zamora et al., 1988; Kovács et al., 1991; Scháfer et al., 
1993; Swartz, 1994; Taylor et al., 1994; Artico et al., 1996; Ecker et al., 
1996; Hewlett et al., 1997; Suzuki et al., 1997). 
In addition, retroviruses can exist in an autonomous state and behave 
like plasmids-before the integration into host cell chromosomal DNA. 
There are evidences that antiplasmid compounds can form a complex 
with plasmid DNA topoisomerase and mdr P-gp, resulting in the reversal of 
j^isLance..Ho-wev-er,_th&-maj^ block replication of 
HIV retrovirus although the reverse transcriptase (RT) and integrase were 
considered potential targets for inhibition of retrovirus replication. The 
search for novel agents has led to the synthesis of some rare phenothiazines 
(Motohashi et al., 1996) and 3-benzazepines (Kawase et al., 1997; Kawase 
et al., 1998b). 
To identify the standard features of 3-benzazepines required for the 
biological activities, the tetrahydro-3-benzazepines were subjected to 
interact with E. coli plasmid DNA, mdr P-gp of lymphoma cells and RT of 
Moloney leukaemia in model experiments. 
Materials and Methods 
Chemicals-The fol lowing six 2,3,4,5-tetrahydro-3-benzazepinones [1-
6] -and three 2,3,4,5-tetrahydro-l/ /-3-benzazepines [7, 8, 10] were newly 
synthesized as recently published (Kawase et al., 1997; Kawase et al., 
1998b). Compound [9] was synthesized, vide literature (Pecherer et al., 
1971). [1] (m.w. 313.38, mp 165-166°C), [2] (m.w. 367.34, mp 102-
103°C), [3] (m.w. 293.26, mp 76°C), [4] (m.w. 353.32, mp 158-160°C), [5] 
(m.w. 395.40, crystals), [6] (m.w. 429.42, mp 175-178°C), [7] (m.w. 
328.13, mp 223°C (dec)), [8] (m.w. 297.70, mp 215°C (dec)), [9] (m.w. 
206.12, mp 241°C (dec)), [10] (m.w. 275.24,. oil). 
DA hydrochloride [11] was purchased from Sigma Chemical Co. (St. 
-Ouis, MO, U.S.A.). N E [12] and rhodamine 123 hydrate (R123, 
ot#28394-0) were purchased f rom Aldrich Chemical Co. (Milwaukee, WI, 
J.S.A.) (Table 1). 
DA [11]) and NE [12]) were used as controls and the compounds were 
issolved in 20% dimethylsulfoxide (DMSO) solution. 
acterial strains. 
E. coli K12 pBR 322 bacterial strain was applied for isolation of 
asmid DNA by agarose gel-electrophoresis (Fig. 1). 
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Table 1. Structures of 2,3,4,5-tetrahydro-1T/-3-
benzazepines [1-10] and two catechols [11,12] 
used in this study3'. 
R ' V N / Y R 
0 3 R 3 
[1-6] [7-10] 
Compound R, R 2 R3 
[1] MeO Ms Me 
[2] MeO Tf Me 
[3 ] H- T f H -
[4] MeO Tf H 
[5] MeO Tf Me 2 CH 
[6] MeO Tf Ph 
[7] HO H CF 3 
[8] HO Me CF 3 
[9] HO H H 
[10] MeO H CF 3 
DA [11] 
NE [12] 
H X n H 2 HO 
O H 
H O . 
H O — N H ; 
a) abbreviations. Me: CH3 Ms: S0 2 CH 3 ; 
Tf: S0 2 CF 3 . 
Fig. 1. Effect of tetrahydrobenzazepines on pBR322 plasmid DNA from E. coli. 
(C-control; ccc-covalently closed circular form; oc-open circular form; lin-linear 
form; and Frg-fragment of DNA 
oc —; 
lin 
C C C — • 
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Antiretroviral effect. Moloney murine leukaemia virus (M-MuLV) RT 
assay. 
Trifluoperazine-metal coordination complexes and 3'-azido-3'-
deoxythymidine triphosphate (AZT-TP) as a control were assayed for their 
ability to inhibit M-MuLV RT (New England BioLabs). The assay is based 
on following: the poly-adenosine phosphate (rA)n . oligo deoxythymidine 
(dT)iMs (New England BioLabs) directed incorporation of deoxythymidine 
triphosphate (dTTP) (Amsterdam) into complementary DNA (cDNA). The 
10 x RT buffer contains 500 mM Trk-HPl (pH R 3), 80 mM MgC!->. 300 
m M KC1, and 100 mM dithiothreitol (DTT). In all experiments, the final 
volume of the reaction assay was 20 [lL. This contained water, 2 liL of 10 x 
R T buffer, 20 fig/mL template-primer, 5 fiM dTTP precursor (New England 
BioLabs), 0.2 [iCi tritiated precursor, the compounds to be tested 
(administrated into the medium before adding the enzyme) and 5 units (U) 
R T initiating the reaction. This procedure was followed by incubation for 
40 min at 37°C. 15 U.L of the mixture was then transferred to Whatman 
DE81 filter paper disc, washed by 5% disodium-hydrophosphate buf fer (3 
x 3 min), water, then 96% ethanol, and after drying and putting into 5 m L 
scintillation cocktail (OptiPhase HiSafe 3', Wallac), the radioactivity was 
measured by Packard Tri-Carb 2200 CE liquid scintillation counter. The 
residual enzymatic activities were compared to the control (no drug added). 
The IC50 of AZT-AT was 0 .12 | iM in our experiments. 
Cell and fluorescence uptake, mdr reversal effect. 
The L5178 mouse T cell lymphoma cell line was infected with the 
pHa MDR1/A retrovirus as previosuly described (Aszalos et al., 1995). 
M D R 1 expressing cell lines were selected by culturing the infected cells 
with 60 ng/mL colchicine to maintain expression of the MDR phenotype. 
The L5178 MDR cell line and the L5178Y parent cell line were grown in 
McCoy 's 5A tissue culture medium with 10% heat-inactivated horse serum, 
L-glutamine and 2 ,3 ,4 ,5- tetrahydro-l t fo-benzazepines [1-10], The cells 
were adjusted to a concentration of 2 x 106/mL and resuspended in serum-
free McCoy's 5A medium and the cells were distributed into 0.5 mL 
aliquote to Eppendorf centr i fuge tubes. Then, the tested compounds were 
added in various concentrations (0.2-20.0 u.L) of the 1.0 mg/mL stock 
solutions and the samples were incubated for 10 min at room temperature. 
Next, 10 jiL (5.2 ijlM final concentration) indicator of rhodamine 123 were 
added to the samples and the cells were incubated for further 20 min at 
37°C, washed twice and resuspended on 0.5 mL phosphate-buffered saline 
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(PBS) for analysis. The fluorescence of cell population was measured by 
f low cytometry using Beckton Dickinson FACScan instrument. Verapamil 
was used as a posit ive control in the rhodamine 123 exclusion exper iments 
(Weaver et ai, 1993). The percentage of control mean f luorescence 
intensity was calculated for the fol lowing equation on the basis of 
measured f luorescence values. 
^ _ mdr treated//;zr/;- control 
parential treated/parental contro l 
Complex formation between benzazepines and plasmid DNA 
The-E—co/rpB-R322"Sl r a i'rTwas grown' i n 3 mL yeast-extract"tTyptone 
broth (YTB) in presence of tetracycline (100 ug/mL) and ampicillin (25 
fig/mJL) at 37°C for 16 hours. The overnight culture was distributed into 1 
m L aliquote in Eppendorf tubes. Benzazepines were added to the plasmid 
containing bacterial suspension in 200 fig/mL final concentrat ion, the 
samples were centr i fuged for 5 min (3000 rpm) and the supernatant was 
discarded. T h e pellet was resuspended in 100 p L o f S o l \ { \ M Tris-HCl, 0 .5 
M glucose, 0.25 M ethylenediaminetetraacetic acid (EDTA)) , homogenized 
in vortex, and incubated at room temperature for 5 min. Then, 200 u L of 
Sol II (10 N NaOH, 2 0 % sodium dodecyl sulfate (SOS)) was added to the 
bacterial suspensions, homogenized and incubated in water bath (0°C) for 5 
min. Then, 150 LIL of ice cold 5 M potassium acetate was added to the 
samples. Af te r mixing, samples were incubated further for 5 min at 0°C, 
then centr i fuged for 10 min (3000 rpm). T h e supernatant was treated with 
200 uL phenol solution and 200 LIL of chloroform: isoamyl alcohol (1:1). 
The samples were centr i fuged for 1 min (3000 rpm) and the supernatants 
were precipitated with 96% ethanol and incubated at room temperature for 
5 min and then precipitated plasmid DNA was centrifuged for 5 min (3000 
rpm). The supernatant was discarded and the plasmid D N A was washed 
with 70% ethanol. Then, ethanol was discarded and the samples were dried 
at 37°C. T h e extracted plasmid DNA was dissolved in 20 uL Tr i s -EDTA 
(TE)-buffer containing RNAse (20 UL/mL, Sigma). 10 LIL of the R N A s e 
treated plasmid D N A solution were applied to 1% agarose gel (with 0.5 
ug /mL ethidium bromide) . Agarose gel electrophoresis was performed for 
20 min (200 V). The various forms of plasmid DNA were detected under 
UV lamp (Fluo-link). 
Resul ts and Discussion 
In the control sample [C], the covaiently closed circular (ccc) form of 
plasmid DNA runs faster than the linear (lin) form and the two 
conformat ions can be seen near to each other (Fig. 1). The open circular 
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(oc) form ran slower, relatively far from linear (Iin) form. In case of 
2 ,3 ,4 ,5-tetrahydro-l /Y-3-benzazepine treated plasmid-containing ce l l s , the 
oc form can be found in each sample. Similar situation exists with lin form. 
However , compounds ([5], [10]) were able to form complexes with the ccc 
form of plasmid D N A . The results showed an evidence for the se lect ive 
c o m p l e x formation of two active benzazepines ([5], [10]) with the 
superhelical form of plasmid D N A , meaning that this biological e f fec t is 
dependent on the substituents of the benzazepine molecule. 
The ccc form of plasmid DNA is maintained by bacterial gyrase 
(topoisomerase) which can be inhibited by benzazepines. Theoretically, it 
is also possible that a simple interaction of two benzazepines ([5], [10]) 
leads to the unwinding of ccc form into the oc form, which is due to a 
single nick introduced into one strand. 
Two compounds ([5], [10]) selectively inactivate the replicative form 
of plasmid D N A that encode the antibiotic resistance (tetracycline (Tc) and 
ampicillin (Ap)) in bacteria. The DA [11] and NE [12] had no effects (data 
not shown). 
When the substituted benzazepines were tested on the P-glycoprotein 
eff lux-pump of tumour cells, only a few compounds were active (Table 2). 
Mdr reversal on tumour cells 
The mdr reversing effects of benzazepines [1-10] by their chemical 
structures were compared to that of verapamil, using a mouse leukaemia 
cell line (L-5178 cells). The effects were measured by fluorescence ratio 
between treated and untreated group cells. Compound [8] has the highest 
activity on mdr reversal (Fluorescence activity ratio 8.3S) among 12 
compounds used in this research and compound [8] was 2-fold more potent 
than verapamil (fluorescence activity ratio 4.18). Then, compound [8] 
might be an anti-mdr inducing agent of great interest, because the affinity 
of [8] to two dopamine D| and D2 receptors was reduced by introduction of 
trifluoromethyl (CF3) group at 2nd position of benzazepine ring (Kawase a 
al., 1998b). 
We have reported that benzazepines [7], [8] and [9] induced apoptic 
cell death in human promyelocytic leukaemia HL-60 cells and the cytotoxic 
activities of [7]-[9] were 1.3. 1.3 and 2.0 times higher than that of DA i l l ] , 
respectively. Additionally, it is found that apoptosis induced by these 
benzazepines [7]-[9] is coupled with their radical generation (Kawase e; 
a!., 199Sa). 
The retroviruses have a key enzyme, which called RT that is 
responsible for maintaining the virus multiplication, the transformation of 
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R N A e n c o d e d information into DNA. This in termedia te s tage of 
retroviral rep l ica t ion w a s e f fec ted by three compounds ([7], [8], [9],) 
( T a b l e 3) (F igure 1). 
T h e resul ts ob t a ined show a chemica l s t ruc ture-dependent e f fec t on 
R T again. T h e ac t ive benzazep ines inhibit the RNA-d i rec ted D N A 
synthes i s , h o w e v e r , the ma jo r i ty of the der ivat ives did not show remarkab le 
Tab le 2. T h e e f f ec t of 2 ,3 ,4 ,5- te t rahydo-1 /7 -3-benzazep ines [ 1 -10] and two ana logues 
[11, 1 2 ] on l y m p h o m a 5178 cells with mul t id rug resistance. 
C o m p o u n d 
[No.] 
par e ) cont ro l 5 0 4 . 8 6 184.75 775 .68 3.03 1060.98 49 .98 
mdr+R 1 23 ^  cont ro l 5 5 2 . 9 5 21 1.52 340.48 1.33 21.23 1.00 
(±) v e r a p a m i l 5 5 4 5 . 7 4 216.62 4 9 9 . 2 0 1.95 88.72 4 .18 
Benz.aze pines: 
[1] 5 4 7 3 . 3 0 188.91 253 .44 0.99 9.85 0 .46 
[2] 5 4 2 5 . 1 6 205.05 325 .12 1.27 18.69 0 .88 
[3] 5 4 9 4 . 5 7 193.54 284 .16 1.11 12.97 0.61 
D ] 5 4 6 7 . 2 9 188.79 309.76 1.21 16.39 0 .77 
[5] 5 4 9 1 . 7 2 190.79 422 .40 1.65 44.77 2.1 1 
[6] 5 5 0 7 . 5 0 197.30 291 .84 1.14 13.S9 0 .65 
[7] 5 4 6 9 . 7 8 187.09 314.8S 1.23 17.01 0 .80 
[8] 5 4 4 7 . 7 7 191.53 576 .00 2.25 177.91 S.3S 
[9] 5 4 7 7 . 2 8 189.43 309.76 1.21 16.12 0 .76 
[10] 5 507 .71 198.41 373 .76 1.46 28.68 1.35 
Dopamines: 
D A [11] 2 5 7 9 . 0 2 251.38 343.04 1.34 21.77 0 .84 
2 0 5 7 1 . 2 0 251.12 350.72 1.37 23.47 0 .93 
N E [12] 2 5 6 9 . 1 0 256.09 340.48 1.33 21.32 0 .82 
2 0 5 6 4 . 1 4 254.11 330.24 1.29 19.53 0 .80 
a) Ref: Kesse l .1989; W e b e r et ai. 1994 
b) x: Measured f l u o r e s c e n c e value at linear scale [mg. uptake of R123], 
c) T h e R-123 accumula t i on w a s calculated f rom f luorescence of one height value using 
1 st eauat ion 
x 
Iog(y)=log | n 256 
then the f luorescence activity ratios were calculated according to the formula given below; 
Ratio - (mdr t r e a t e d I m d r control) 
(parental t rea ted/parenta l control) 
d) (±)verapami l : a control for mdr reversal 
e) par: parental wi thout mul t id rug resistant gene. 
0 mdr. parental wi th mu l t i d rug resistant gene. 
C o n c e n - F o r w a r d Side scatter Fluorescence one height Fluore-
trat ion scat ter height value scence 
( p g / m L ) he igh t [granulat ion ~ . . 
[cell s ize of cell ratio] x b y * log(y)=log | 0 256 
ratio] 200 ratio 
; ; ! i i - jM-vTi KPl M - • -
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Tabic 3. Inhibition of Moloney murine leukaemia virus rever 
transcriptase by 2.3.4.5-tctrahydro-1 7/-3-benzazepincs [1-10] 
In concentration (I0~5AT). 
Compound 
(No.) 
Concen-
tration 
(Ug/mL) 
Activity 
of cDNA 
(DPMX" 
Activity in 
pcrccntage 
of DMSO 
control (%) 
DMSO (control) 6 7 4 0 1 100 
0.5 pL DMSO/ 5 4 8 S 7 
20 pL assay 5 0 2 9 7 
6 4 7 S 4 
+ Control S 3 2 4 5 -
5 7 4 0 8 
M 5 0 3 9 3 5 2 S S . 2 
6 0 S 3 2 
[2] 5 0 4 9 6 4 9 8 9 . 1 
5 4 1 0 4 
P ) 5 0 4 8 9 4 9 8 0 . 4 
4 5 5 9 1 
IT 5 0 6 3 0 9 S 1 1 2 6 
6 6 S 6 2 
[5] 5 0 ¿ 6 2 1 4 9 S . 7 
5 8 1 5 3 
[61 5 0 3 1 2 4 9 7 2 1 
5 2 9 5 0 
[7] 5 0 2 3 7 2 S 
1 7 7 C 4 
3 2 . 6 
[S] 5 0 
I _» / J -R 
1 7 S 7 3 2 9 . 5 
1 7 3 0 5 
[9] 5 0 1 5 5 3 6 21 S 
1 0 1 2 6 
[10] 5 0 6 0 2 4 2 ¡ 0 2 6 
5 6 S 0 5 
"DPM: decomposition per minute ¡alternative to 
count per minute (cpm) values). 
effects in the system These derivatives possibly might modify the enzyme 
activity by binding to benzazepine b inding sites on RT-enzvme. 
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